Particle weakening in superplastic SiC/2124 Al composites at high temperature
Kim, W. J., & Sherby, O. D. (2000). Particle weakening in superplastic SiC/2124 Al composites at high temperature. ACTA MATERIALIA, 48(8), 1763–74.

Comparative Effectiveness of Telaprevir-Based Triple Therapy in Patients With Chronic Hepatitis C
Al-Bawardy, B., Kim, W. R., Poterucha, J. J., Gross, J. B., Charlton, M. R., Larson, J. J., … Therneau, T. M. (2014). Comparative Effectiveness of Telaprevir-Based Triple Therapy in Patients With Chronic Hepatitis C. MAYO CLINIC PROCEEDINGS, 89(5), 595–601.

Continuation of metformin use after a diagnosis of cirrhosis significantly improves survival of patients with diabetes.
Zhang, X., Harmsen, W. S., Mettler, T. A., Kim, W. R., Roberts, R. O., Therneau, T. M., … Chaiteerakij, R. (2014). Continuation of metformin use after a diagnosis of cirrhosis significantly improves survival of patients with diabetes. Hepatology (Baltimore, Md.).

Chronic kidney disease and associated mortality after liver transplantation - A time-dependent analysis using measured glomerular filtration rate
Allen, A. M., Kim, W. R., Therneau, T. M., Larson, J. J., Heimbach, J. K., & Rule, A. D. (2014). Chronic kidney disease and associated mortality after liver transplantation - A time-dependent analysis using measured glomerular filtration rate. JOURNAL OF HEPATOLOGY, 61(2), 286–92.

Validation of a model to estimate survival in ambulatory patients with hepatocellular carcinoma: a single-centre cohort study
Kim, B. H., Park, J.-W., Nam, B.-ho, Kwak, H. W., & Kim, W. R. (2014). Validation of a model to estimate survival in ambulatory patients with hepatocellular carcinoma: a single-centre cohort study. LIVER INTERNATIONAL, 34(7), E317–E323.

Effect of the Pretransplant Serum Sodium Concentration on Outcomes Following Liver Transplantation
Leise, M. D., Yun, B. C., Larson, J. J., Benson, J. T., Yang, J. D., Therneau, T. M., … Kim, W. R. (2014). Effect of the Pretransplant Serum Sodium Concentration on Outcomes Following Liver Transplantation. LIVER TRANSPLANTATION, 20(6), 687–97.

Efficacy and Safety of Treatment of Hepatitis C in Patients With Inflammatory Bowel Disease
Allen, A. M., Kim, W. R., Larson, J., & Loftus, E. V. (2013). Efficacy and Safety of Treatment of Hepatitis C in Patients With Inflammatory Bowel Disease. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 11(12), 1655–U321.

Impact of the center on graft failure after liver transplantation
Asrani, S. K., Kim, W. R., Edwards, E. B., Larson, J. J., Thabut, G., Kremers, W. K., … Heimbach, J. (2013). Impact of the center on graft failure after liver transplantation. LIVER TRANSPLANTATION, 19(9), 957–64.

Hepatitis B Screening and Vaccination Practices in Asian American Primary Care
Chu, D., Yang, J. D., Lok, A. S., Tram Tran, T., Martins, E. B., Fagan, E., … Kim, W. R. (2013). Hepatitis B Screening and Vaccination Practices in Asian American Primary Care. GUT AND LIVER, 7(4), 450–457.

Nonalcoholic fatty liver disease associated with coronary artery calcification
Kim, D., Choi, S. Y., Park, E. H., Lee, W., Kang, J. H., Kim, W., … Kim, W. R. (2012). Nonalcoholic fatty liver disease associated with coronary artery calcification. Hepatology, 56(2).

Hospitalization for Underage Drinkers in the United States
Kim, J. Y., Asrani, S. K., Shah, N. D., Kim, W. R., & Schneekloth, T. D. (2012). Hospitalization for Underage Drinkers in the United States. JOURNAL OF ADOLESCENT HEALTH, 50(6), 648–50.

Nonalcoholic fatty liver disease is associated with coronary artery calcification
Kim, D., Choi, S.-Y., Park, E. H., Lee, W., Kang, J. H., Kim, W., … Kim, W. R. (2012). Nonalcoholic fatty liver disease is associated with coronary artery calcification. HEPATOLOGY, 56(2), 605–613.

Simultaneous Liver-Kidney Transplantation Summit: Current State and Future Directions
Nadim, M. K., Sung, R. S., Davis, C. L., Andreoni, K. A., Biggins, S. W., Danovitch, G. M., … Genyk, Y. S. (2012). Simultaneous Liver-Kidney Transplantation Summit: Current State and Future Directions. AMERICAN JOURNAL OF TRANSPLANTATION, 12(11), 2901–2908.

Surveillance for Hepatocellular Carcinoma in Patients With Cirrhosis
Yang, J. D., & Kim, W. R. (2012). Surveillance for Hepatocellular Carcinoma in Patients With Cirrhosis. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 10(1), 16–21.

Factors That Affect Risk for Hepatocellular Carcinoma and Effects of Surveillance
Yang, J. D., Harmsen, W. S., Slettedahl, S. W., Chaiteerakij, R., Enders, F. T., Therneau, T. M., … Roberts, L. R. (2011). Factors That Affect Risk for Hepatocellular Carcinoma and Effects of Surveillance. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 9(7), 617–U141.

Humanistic and economic impacts of hepatitis C infection in the United States.
DiBonaventura, M. D., Wagner, J.-S., Yuan, Y., L'Italien, G., Langley, P., & Ray Kim, W. (2010). Humanistic and economic impacts of hepatitis C infection in the United States. Journal of Medical Economics, 13(4), 709–718.

Utility of Serum YKL-40 as a Tumor-Specific Marker of Hepatobiliary Malignancies
Yang, J. D., Kim, E., Pedersen, R. A., Kim, W. R., Pungpapong, S., & Roberts, L. R. (2010). Utility of Serum YKL-40 as a Tumor-Specific Marker of Hepatobiliary Malignancies. GUT AND LIVER, 4(4), 537–42.

Many Patients With Primary Sclerosing Cholangitis and Increased Serum Levels of Carbohydrate Antigen 19-9 Do Not Have Cholangiocarcinoma
Sinakos, E., Saenger, A. K., Keach, J., Kim, W. R., & Lindor, K. D. (2011). Many Patients With Primary Sclerosing Cholangitis and Increased Serum Levels of Carbohydrate Antigen 19-9 Do Not Have Cholangiocarcinoma. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 9(5), 434–U1433.

A Revised Model for End-Stage Liver Disease Optimizes Prediction of Mortality Among Patients Awaiting Liver Transplantation
Leise, M. D., Kim, W. R., Kremers, W. K., Larson, J. J., Benson, J. T., & Therneau, T. M. (2011). A Revised Model for End-Stage Liver Disease Optimizes Prediction of Mortality Among Patients Awaiting Liver Transplantation. GASTROENTEROLOGY, 140(7), 1952–60.

Endothelial Nitric Oxide Synthase Gene Variation Associated With Chronic Kidney Disease After Liver Transplant
Bambha, K., Kim, W. R., Rosen, C. B., Pedersen, R. A., Rys, C., Kolbert, C. P., … Therneau, T. M. (2010). Endothelial Nitric Oxide Synthase Gene Variation Associated With Chronic Kidney Disease After Liver Transplant. MAYO CLINIC PROCEEDINGS, 85(9), 814–820.

Cirrhosis Is Present in Most Patients With Hepatitis B and Hepatocellular Carcinoma
Yang, J. D., Kim, W. R., Coelho, R., Mettler, T. A., Benson, J. T., Sanderson, S. O., … Roberts, L. R. (2011). Cirrhosis Is Present in Most Patients With Hepatitis B and Hepatocellular Carcinoma. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 9(1), 64–70.

Development of organ-specific donor risk indices
Akkina, S. K., Asrani, S. K., Peng, Y., Stock, P., Kim, W. R., & Israni, A. K. (2012). Development of organ-specific donor risk indices. LIVER TRANSPLANTATION, 18(4), 395–404.

Kidney, Pancreas and Liver Allocation and Distribution in the United States
Smith, J. M., Biggins, S. W., Haselby, D. G., Kim, W. R., Wedd, J., Lamb, K., … Israni, A. K. (2012). Kidney, Pancreas and Liver Allocation and Distribution in the United States. AMERICAN JOURNAL OF TRANSPLANTATION, 12(12), 3191–3212.

Risk Prediction of Hepatocellular Carcinoma in Patients with Cirrhosis: The ADRESS-HCC Risk Model
Flemming, J. A., Vittinghoff, E., Kim, W. R., & Terrault, N. (2013). Risk Prediction of Hepatocellular Carcinoma in Patients with Cirrhosis: The ADRESS-HCC Risk Model. Presented at the 64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, WASHINGTON,DC: WILEY-BLACKWELL.

Underestimation of Liver-Related Mortality in the United States
Asrani, S. K., Larson, J. J., Yawn, B., Therneau, T. M., & Kim, W. R. (2013). Underestimation of Liver-Related Mortality in the United States. GASTROENTEROLOGY, 145(2), 375-?

Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers.
Darwish Murad, S., Kim, W. R., Harnois, D. M., Douglas, D. D., Burton, J., Kulik, L. M., … Heimbach, J. K. (2012). Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US centers. Gastroenterology, 143(1), 88–98 e3.

Biliary Tract Cancers in Olmsted County, Minnesota, 1976-2008
Yang, J. D., Kim, B., Sanderson, S. O., St Sauver, J., Yawn, B. P., Larson, J. J., … Kim, W. R. (2012). Biliary Tract Cancers in Olmsted County, Minnesota, 1976-2008. AMERICAN JOURNAL OF GASTROENTEROLOGY, 107(8), 1256–62.

Model to estimate survival in ambulatory patients with hepatocellular carcinoma
Yang, J. D., Kim, W. R., Park, K. W., Chaiteerakij, R., Kim, B., Sanderson, S. O., … Park, J.-W. (2012). Model to estimate survival in ambulatory patients with hepatocellular carcinoma. HEPATOLOGY, 56(2), 614–21.

Predictors of pretransplant dropout and posttransplant recurrence in patients with perihilar cholangiocarcinoma
Murad, S. D., Kim, W. R., Therneau, T., Gores, G. J., Rosen, C. B., Martenson, J. A., … Heimbach, J. K. (2012). Predictors of pretransplant dropout and posttransplant recurrence in patients with perihilar cholangiocarcinoma. HEPATOLOGY, 56(3), 972–81.

Risk Factors for Intrahepatic Cholangiocarcinoma: Association Between Metformin Use and Reduced Cancer Risk
Chaiteerakij, R., Yang, J. D., Harmsen, W. S., Slettedahl, S. W., Mettler, T. A., Fredericksen, Z. S., … Roberts, L. R. (2013). Risk Factors for Intrahepatic Cholangiocarcinoma: Association Between Metformin Use and Reduced Cancer Risk. HEPATOLOGY, 57(2), 648–55.

Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: Noninvasive Assessment with MR Elastography
Kim, D., Kim, W. R., Talwalkar, J. A., Kim, H. J., & Ehman, R. L. (2013). Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: Noninvasive Assessment with MR Elastography. RADIOLOGY, 268(2), 411–19.

Predicting clinical outcomes with elastography in primary biliary cirrhosis: one step closer?
Singh, S., Kim, W. R., & Talwalkar, J. A. (2013). Predicting clinical outcomes with elastography in primary biliary cirrhosis: one step closer? Gastroenterology, 144(4), 851–52.

Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States
Kim, D., Kim, W. R., Kim, H. J., & Therneau, T. M. (2013). Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States. HEPATOLOGY, 57(4), 1357–65.

Excellent quality of life after liver transplantation for patients with perihilar cholangiocarcinoma who have undergone neoadjuvant chemoradiation
Murad, S. D., Heimbach, J. K., Gores, G. J., Rosen, C. B., Benson, J. T., & Kim, W. R. (2013). Excellent quality of life after liver transplantation for patients with perihilar cholangiocarcinoma who have undergone neoadjuvant chemoradiation. LIVER TRANSPLANTATION, 19(5), 521–28.

The impact of hepatitis C on labor force participation, absenteeism, presenteeism and non-work activities.
DiBonaventura, M. D., Wagner, J.-S., Yuan, Y., L'Italien, G., Langley, P., & Ray Kim, W. (2011). The impact of hepatitis C on labor force participation, absenteeism, presenteeism and non-work activities. Journal of Medical Economics, 14(2), 253–261.

The impact of hepatitis C burden: an evidence-based approach
Younossi, Z. M., Kanwal, F., Saab, S., Brown, K. A., El-Serag, H. B., Kim, W. R., … Gordon, S. C. (2014). The impact of hepatitis C burden: an evidence-based approach. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 39(5), 518–31.

Coffee: a panacea or snake oil for the liver?
Kumari, R., & Kim, W. R. (2014). Coffee: a panacea or snake oil for the liver? Clinical Gastroenterology and Hepatology , 12(9), 1569–71.

Sofosbuvir and simeprevir combination therapy in the setting of liver transplantation and hemodialysis
Perumpail, R. B., Wong, R. J., Ha, L. D., Pham, E. A., Wang, U., Luong, H., … Ahmed, A. (2015). Sofosbuvir and simeprevir combination therapy in the setting of liver transplantation and hemodialysis. TRANSPLANT INFECTIOUS DISEASE, 17(2), 275–78.

Survival after liver transplantation: is racial disparity inevitable?
Lee, T. H., Shah, N., Pedersen, R. A., Kremers, W. K., Rosen, C. B., Klintmalm, G. B., & Kim, W. R. (2007). Survival after liver transplantation: is racial disparity inevitable? HEPATOLOGY, 46(5), 1491–97.

Survival of Recipients of Livers From Donation After Circulatory Death Who Are Relisted and Undergo Retransplant for Graft Failure
Allen, A. M., Kim, W. R., Xiong, H., Liu, J., Stock, P. G., Lake, J. R., … Kasiske, B. L. (2014). Survival of Recipients of Livers From Donation After Circulatory Death Who Are Relisted and Undergo Retransplant for Graft Failure. AMERICAN JOURNAL OF TRANSPLANTATION, 14(5), 1120–28.

Delayed Hepatocellular Carcinoma Model for End-Stage Liver Disease Exception Score Improves Disparity in Access to Liver Transplant in the United States
Heimbach, J. K., Hirose, R., Stock, P. G., Schladt, D. P., Xiong, H., Liu, J., … Kim, W. R. (2015). Delayed Hepatocellular Carcinoma Model for End-Stage Liver Disease Exception Score Improves Disparity in Access to Liver Transplant in the United States. HEPATOLOGY, 61(5), 1643–50.

Current and Future Burden of Chronic Nonmalignant Liver Disease.
Udompap, P., Kim, D., & Kim, W. R. (2015). Current and Future Burden of Chronic Nonmalignant Liver Disease. Clinical Gastroenterology and Hepatology , 13(12), 2031–41.

A glass half full: Implications of screening for hepatitis C virus in the era of highly effective antiviral therapy.
Lutchman, G., & Kim, W. R. (2015). A glass half full: Implications of screening for hepatitis C virus in the era of highly effective antiviral therapy. Hepatology , 61(5), 1455–58.

Increasing prevalence of cirrhosis among U.S. adults aware or unaware of their chronic hepatitis C virus infection.
Udompap, P., Mannalithara, A., Heo, N.-Y., Kim, D., & Kim, W. R. (2016). Increasing prevalence of cirrhosis among U.S. adults aware or unaware of their chronic hepatitis C virus infection. Journal of Hepatology, 64(5), 1027–32.

Entecavir safety and effectiveness in a national cohort of treatment-naive chronic hepatitis B patients in the US - the ENUMERATE study
Ahn, J., Lee, H. M., Lim, J. K., Pan, C. Q., Nguyen, M. H., Kim, W. R., … Lok, A. S. (2016). Entecavir safety and effectiveness in a national cohort of treatment-naive chronic hepatitis B patients in the US - the ENUMERATE study. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 43(1), 134–44.

Korean Version of a Model to Estimate Survival in Ambulatory Patients with Hepatocellular Carcinoma (K-MESIAH)
Nam, B.-ho, Park, J.-W., Jeong, S.-H., Lee, S. S., Yu, A., Kim, B. H., & Kim, W. R. (2015). Korean Version of a Model to Estimate Survival in Ambulatory Patients with Hepatocellular Carcinoma (K-MESIAH). PLOS ONE, 10(10).

Hepatitis B Virus-Specific and Global T-Cell Dysfunction in Chronic Hepatitis B
Park, J.-J., Wong, D. K., Wahed, A. S., Lee, W. M., Feld, J. J., Terrault, N., … Chang, K.-M. (2016). Hepatitis B Virus-Specific and Global T-Cell Dysfunction in Chronic Hepatitis B. GASTROENTEROLOGY, 150(3), 684-?

Lower Observed Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Patients Treated With Entecavir: Results of the ENUMERATE Study.
Ahn, J., Lim, J. K., Lee, H. M., Lok, A. S., Nguyen, M., Pan, C. Q., … Kim, W. R. (2016). Lower Observed Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Patients Treated With Entecavir: Results of the ENUMERATE Study. American Journal of Gastroenterology, 111(9), 1297–1304.

The Epidemiology of Liver Diseases Unique to Pregnancy in a US Community: A Population-Based Study
Allen, A. M., Kim, W. R., Larson, J. J., Rosedahl, J. K., Yawn, B. P., McKeon, K., & Hay, J. E. (2016). The Epidemiology of Liver Diseases Unique to Pregnancy in a US Community: A Population-Based Study. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 14(2), 287-?

Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients
Kim, W. R., Berge, T., Asselah, T., Flisiak, R., Fung, S., Gordon, S. C., … Marcellin, P. (2016). Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients. JOURNAL OF HEPATOLOGY, 64(4), 773–80.

Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients.
Kim, W. R., Berg, T., Asselah, T., Flisiak, R., Fung, S., Gordon, S. C., … Marcellin, P. (2016). Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients. Journal of Hepatology, 64(4), 773–80.

Potential Efficacy of Pegylated Interferon-alpha and a Nucleos(t)ide Analogue as Combination Therapy for HBeAg-Positive Chronic Hepatitis B
Wi, C.-I., Kim, W. R., Gross, J. B., Stadheim, L. M., & Poterucha, J. J. (2016). Potential Efficacy of Pegylated Interferon-alpha and a Nucleos(t)ide Analogue as Combination Therapy for HBeAg-Positive Chronic Hepatitis B. GUT AND LIVER, 10(4), 611–16.

Nonobese Fatty Liver Disease.
Kim, D., & Kim, W. R. (2016). Nonobese Fatty Liver Disease. Clinical Gastroenterology and Hepatology .

An ALTer Ego of Serum ALT: Is It More Than a Marker of Liver Inflammation?
Kim, D., & Kim, W. R. (2013). An ALTer Ego of Serum ALT: Is It More Than a Marker of Liver Inflammation? GASTROENTEROLOGY, 145(6), 1191–93.

Predicting Outcomes on the Liver Transplant Waiting List in the United States: Accounting for Large Regional Variation in Organ Availability and Priority Allocation Points.
Hart, A., Schladt, D. P., Zeglin, J., Pyke, J., Kim, W. R., Lake, J. R., … Israni, A. K. (2016). Predicting Outcomes on the Liver Transplant Waiting List in the United States: Accounting for Large Regional Variation in Organ Availability and Priority Allocation Points. Transplantation, 100(10), 2153–59.

Time trends in the health care burden and mortality of acute on chronic liver failure in the United States.
Allen, A. M., Kim, W. R., Moriarty, J. P., Shah, N. D., Larson, J. J., & Kamath, P. S. (2016). Time trends in the health care burden and mortality of acute on chronic liver failure in the United States. Hepatology .

Impact of Long-Term Tenofovir Disoproxil Fumarate on Incidence of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
Kim, W. R., Loomba, R., Berg, T., Schall, R. E. A., Yee, L. J., Dinh, P. V., … Marcellin, P. (2015). Impact of Long-Term Tenofovir Disoproxil Fumarate on Incidence of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B. CANCER, 121(20), 3631–38.

A revised natural history model for primary sclerosing cholangitis
Kim, W. R., Therneau, T. M., Wiesner, R. H., Poterucha, J. J., Benson, J. T., Malinchoc, M., … Dickson, E. R. (2000). A revised natural history model for primary sclerosing cholangitis. MAYO CLINIC PROCEEDINGS, 75(7), 688–94.

Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation
Kim, W. R., Poterucha, J. J., Jorgensen, R. A., Batts, K. P., Homburger, H. A., Dickson, E. R., … Lindor, K. D. (1997). Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation. HEPATOLOGY, 26(1), 22–26.

Low Level of Hepatitis B Virus Screening Among Patients Receiving Chemotherapy
Wi, C.-I., Loo, N. M., Larson, J. J., Moynihan, T. J., Madde, N. R., Grendahl, D. C., … Kim, W. R. (2015). Low Level of Hepatitis B Virus Screening Among Patients Receiving Chemotherapy. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 13(5), 970–75.

Natural history of hepatitis B virus infection: An update for clinicians
Pungpapong, S., Kim, W. R., & Poterucha, J. J. (2007). Natural history of hepatitis B virus infection: An update for clinicians. MAYO CLINIC PROCEEDINGS, 82(8), 967–75.

Serum aminotransferase activity and mortality risk in a United States community
Lee, T. H., Kim, W. R., Benson, J. T., Therneau, T. M., & Melton, L. J. (2008). Serum aminotransferase activity and mortality risk in a United States community. HEPATOLOGY, 47(3), 880–87.

Serum Cystatin Cas an Indicator of Renal Function and Mortality in Liver Transplant Recipients
Allen, A. M., Kim, W. R., Larson, J. J., Colby, C., Therneau, T. M., & Rule, A. D. (2015). Serum Cystatin Cas an Indicator of Renal Function and Mortality in Liver Transplant Recipients. TRANSPLANTATION, 99(7), 1431–35.

Reliability and validity of the NIDDK-QA instrument in the assessment of quality of life in ambulatory patients with cholestatic liver disease
Kim, W. R., Lindor, K. D., Malinchoc, M., Petz, J. L., Jorgensen, R., & Dickson, E. R. (2000). Reliability and validity of the NIDDK-QA instrument in the assessment of quality of life in ambulatory patients with cholestatic liver disease. HEPATOLOGY, 32(5), 924–29.

Medical and economic impact of autoimmune hepatitis.
Talwalkar, J. A., & Kim, W. R. (2002). Medical and economic impact of autoimmune hepatitis. Clinics in Liver Disease, 6(3), 649–67.

Quality of life before and after liver transplantation for cholestatic liver disease
Gross, C. R., Malinchoc, M., Kim, W. R., Evans, R. W., Wiesner, R. H., Petz, J. L., … Dickson, E. R. (1999). Quality of life before and after liver transplantation for cholestatic liver disease. HEPATOLOGY, 29(2), 356–64.

Preoperative predictors of resource utilization in liver transplantation.
Kim, W. R., Therneau, T. M., Dickson, E. R., & Evans, R. W. (1995). Preoperative predictors of resource utilization in liver transplantation. Clinical Transplants, 315–22.

Serum sodium, renal function, and survival of patients with end-stage liver disease
Lim, Y.-S., Larson, T. S., Benson, J. T., Kamath, P. S., Kremers, W. K., Therneau, T. M., & Kim, W. R. (2010). Serum sodium, renal function, and survival of patients with end-stage liver disease. JOURNAL OF HEPATOLOGY, 52(4), 523–28.

Epidemiology and Healthcare Burden of Acute-on-Chronic Liver Failure
Allen, A. M., & Kim, W. R. (2016). Epidemiology and Healthcare Burden of Acute-on-Chronic Liver Failure. SEMINARS IN LIVER DISEASE, 36(2), 123–26.

Variant forms of cholestatic diseases involving small bile ducts in adults
Kim, W. R., Ludwig, J., & Lindor, K. D. (2000). Variant forms of cholestatic diseases involving small bile ducts in adults. AMERICAN JOURNAL OF GASTROENTEROLOGY, 95(5), 1130–38.

MELD accurately predicts mortality in patients with alcoholic hepatitis
Dunn, W., Jamil, L. H., Brown, L. S., Wiesner, R. H., Kim, W. R., Menon, K. V. N., … Shah, V. (2005). MELD accurately predicts mortality in patients with alcoholic hepatitis. HEPATOLOGY, 41(2), 353–58.

Management of Hepatic Encephalopathy in the Hospital
Leise, M. D., Poterucha, J. J., Kamath, P. S., & Kim, W. R. (2014). Management of Hepatic Encephalopathy in the Hospital. MAYO CLINIC PROCEEDINGS, 89(2), 241–53.

Deaths on the liver transplant waiting list: An analysis of competing risks
Kim, W. R., Therneau, T. M., Benson, J. T., Kremers, W. K., Rosen, C. B., Gores, G. J., & Dickson, E. R. (2006). Deaths on the liver transplant waiting list: An analysis of competing risks. HEPATOLOGY, 43(2), 345–51.

The use of decision analytic models to inform clinical decision making in the management of hepatocellular carcinoma.
Kim, W. R. (2005). The use of decision analytic models to inform clinical decision making in the management of hepatocellular carcinoma. Clinics in Liver Disease, 9(2), 225–34.

The role of prognostic models in the timing of liver transplantation. Application in cholestatic liver diseases.
Kim, W. R., & Dickson, E. R. (1997). The role of prognostic models in the timing of liver transplantation. Application in cholestatic liver diseases. Clinics in Liver Disease, 1(2), 263-?

Born to be wild or just confused? Genetic predisposition to hepatic encephalopathy.
Duarte-Rojo, A., Kamath, P. S., & Kim, W. R. (2011). Born to be wild or just confused? Genetic predisposition to hepatic encephalopathy. Gastroenterology, 140(7), 2137–38.

Hepatocellular Carcinoma in Olmsted County, Minnesota, 1976-2008
Yang, J. D., Kim, B., Sanderson, S. O., St Sauver, J. L., Yawn, B. P., Pedersen, R. A., … Kim, W. R. (2012). Hepatocellular Carcinoma in Olmsted County, Minnesota, 1976-2008. MAYO CLINIC PROCEEDINGS, 87(1), 9–16.

Predictive models of natural history in primary biliary cirrhosis.
Kim, W. R., & Dickson, E. R. (1998). Predictive models of natural history in primary biliary cirrhosis. Clinics in Liver Disease, 2(2), 313-?

Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis
Yang, J. D., Mohamed, H. A., Cvinar, J. L., Gores, G. J., Roberts, L. R., & Kim, W. R. (2016). Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis. AMERICAN JOURNAL OF GASTROENTEROLOGY, 111(11), 1572–80.

Lower Observed Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Patients Treated With Entecavir: Results of the ENUMERATE Study
Ahn, J., Lim, J. K., Lee, H. M., Lok, A. S., Mindie Nguyen, M., Pan, C. Q., … Kim, W. R. (2016). Lower Observed Hepatocellular Carcinoma Incidence in Chronic Hepatitis B Patients Treated With Entecavir: Results of the ENUMERATE Study. AMERICAN JOURNAL OF GASTROENTEROLOGY, 111(9), 1297–1304.

Management of Renal Failure in End-Stage Liver Disease: A Critical Appraisal
Cheng, X. S., Tan, J. C., & Kim, W. R. (2016). Management of Renal Failure in End-Stage Liver Disease: A Critical Appraisal. LIVER TRANSPLANTATION, 22(12), 1710–19.

Diabetes and prediabetes in patients with hepatitis B residing in North America
Khalili, M., Lombardero, M., Chung, R. T., Terrault, N. A., Ghany, M. G., Kim, W. R., … Lok, A. S. (2015). Diabetes and prediabetes in patients with hepatitis B residing in North America. HEPATOLOGY, 62(5), 1364–74.

Characteristics of Adults in the Hepatitis B Research Network in North America Reflect Their Country of Origin and Hepatitis B Virus Genotype
Ghany, M. G., Perrillo, R., Li, R., Belle, S. H., Janssen, H. la, Terrault, N. A., … Lok, A. S.-F. (2015). Characteristics of Adults in the Hepatitis B Research Network in North America Reflect Their Country of Origin and Hepatitis B Virus Genotype. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 13(1), 183–92.

Improved Post-Transplant Mortality After Share 35 for Liver Transplantation.
Kwong, A. J., Goel, A., Mannalithara, A., & Kim, W. R. (2017). Improved Post-Transplant Mortality After Share 35 for Liver Transplantation. Hepatology (Baltimore, Md.).

Utility in Treating Kidney Failure in End-Stage Liver Disease With Simultaneous Liver-Kidney Transplantation
Cheng, X. S., Stedman, M. R., Chertow, G. M., Kim, W. R., & Tan, J. C. (2017). Utility in Treating Kidney Failure in End-Stage Liver Disease With Simultaneous Liver-Kidney Transplantation. TRANSPLANTATION, 101(5), 1111–19.

PERSPECTIVES IN CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
Kim, D., & Kim, W. R. (2017). PERSPECTIVES IN CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 15(4), 474–85.

Reduction in Liver Transplant Wait-Listing in the Era of Direct-Acting Antiviral Therapy
Flemming, J. A., Kim, W. R., Brosgart, C. L., & Terrault, N. A. (2017). Reduction in Liver Transplant Wait-Listing in the Era of Direct-Acting Antiviral Therapy. HEPATOLOGY, 65(3), 804–12.

Beneficial and harmful effects of nonselective beta blockade on acute kidney injury in liver transplant candidates.
Kim, S. G., Larson, J. J., Lee, J. S., Therneau, T. M., & Kim, W. R. (2017). Beneficial and harmful effects of nonselective beta blockade on acute kidney injury in liver transplant candidates. Liver Transplantation , 23(6), 733–40.

Risk Prediction of Hepatocellular Carcinoma in Patients With Cirrhosis: The ADRESS-HCC Risk Model
Flemming, J. A., Yang, J. D., Vittinghoff, E., Kim, W. R., & Terrault, N. A. (2014). Risk Prediction of Hepatocellular Carcinoma in Patients With Cirrhosis: The ADRESS-HCC Risk Model. CANCER, 120(22), 3485–93.

Assessing the cost utility of response-guided therapy in patients with chronic hepatitis C genotype 1 in the UK using the MONARCH model.
McEwan, P., Kim, R., & Yuan, Y. (2013). Assessing the cost utility of response-guided therapy in patients with chronic hepatitis C genotype 1 in the UK using the MONARCH model. Applied Health Economics and Health Policy, 11(1), 53–63.

Efficacy of Neoadjuvant Chemoradiation, Followed by Liver Transplantation, for Perihilar Cholangiocarcinoma at 12 US Centers
Murad, S. D., Kim, W. R., Harnois, D. M., Douglas, D. D., Burton, J., Kulik, L. M., … Heimbach, J. K. (2012). Efficacy of Neoadjuvant Chemoradiation, Followed by Liver Transplantation, for Perihilar Cholangiocarcinoma at 12 US Centers. GASTROENTEROLOGY, 143(1), 88–U610.

Hyponatremia and mortality among patients on the liver-transplant waiting list
Kim, W. R., Biggins, S. W., Kremers, W. K., Wiesner, R. H., Kamath, P. S., Benson, J. T., … Therneau, T. M. (2008). Hyponatremia and mortality among patients on the liver-transplant waiting list. NEW ENGLAND JOURNAL OF MEDICINE, 359(10), 1018–26.

Hepatic retransplantation in cholestatic liver disease: Impact of the interval to retransplantation on survival and resource utilization
Kim, W. R., Wiesner, R. H., Poterucha, J. J., Therneau, T. M., Malinchoc, M., Benson, J. T., … Dickson, E. R. (1999). Hepatic retransplantation in cholestatic liver disease: Impact of the interval to retransplantation on survival and resource utilization. HEPATOLOGY, 30(2), 395–400.

Evidence-based incorporation of serum sodium concentration into MELD
Biggins, S. W., Kim, W. R., Terrault, N. A., Saab, S., Balan, V., Schiano, T., … Klintmalm, G. (2006). Evidence-based incorporation of serum sodium concentration into MELD. GASTROENTEROLOGY, 130(6), 1652–60.

Protecting the Kidney in Liver Transplant Candidates: Practice-Based Recommendations From the American Society of Transplantation Liver and Intestine Community of Practice
O'Leary, J. G., Levitsky, J., Wong, F., Nadim, M. K., Charlton, M., & Kim, W. R. (2016). Protecting the Kidney in Liver Transplant Candidates: Practice-Based Recommendations From the American Society of Transplantation Liver and Intestine Community of Practice. AMERICAN JOURNAL OF TRANSPLANTATION, 16(9), 2516–31.

Mortality and hospital utilization for hepatocellular carcinoma in the United States
Kim, W. R., Gores, G. J., Benson, J. T., Therneau, T. M., & Melton, L. J. (2005). Mortality and hospital utilization for hepatocellular carcinoma in the United States. GASTROENTEROLOGY, 129(2), 486–93.

Donor Race Does Not Predict Graft Failure After Liver Transplantation
Asrani, S. K., Lim, Y.-S., Therneau, T. M., Pedersen, R. A., Heimbach, J., & Kim, W. R. (2010). Donor Race Does Not Predict Graft Failure After Liver Transplantation. GASTROENTEROLOGY, 138(7), 2341–47.

Trends in Waiting List Registration for Liver Transplantation for Viral Hepatitis in the United States
Kim, W. R., Terrault, N. A., Pedersen, R. A., Therneau, T. M., Edwards, E., Hindman, A. A., & Brosgart, C. L. (2009). Trends in Waiting List Registration for Liver Transplantation for Viral Hepatitis in the United States. GASTROENTEROLOGY, 137(5), 1680–86.

Impact of Pretransplant Hyponatremia on Outcome Following Liver Transplantation
Yun, B. C., Kim, W. R., Benson, J. T., Biggins, S. W., Therneau, T. M., Kremers, W. K., … Klintmalm, G. B. (2009). Impact of Pretransplant Hyponatremia on Outcome Following Liver Transplantation. HEPATOLOGY, 49(5), 1610–15.

Short Sleep Duration Is Associated With Abnormal Serum Aminotransferase Activities and Nonalcoholic Fatty Liver Disease.
Kim, D., Kim, H. J., Kushida, C. A., Heo, N.-Y. Y., Ahmed, A., & Kim, W. R. (2017). Short Sleep Duration Is Associated With Abnormal Serum Aminotransferase Activities and Nonalcoholic Fatty Liver Disease. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Long-term Patient and Graft Survival of Kidney Transplant Recipients with Hepatitis C Virus Infection in the United States.
Heo, N.-Y. Y., Mannalithara, A., Kim, D., Udompap, P., Tan, J. C., & Kim, W. R. (2017). Long-term Patient and Graft Survival of Kidney Transplant Recipients with Hepatitis C Virus Infection in the United States. Transplantation.

Nonalcoholic Fatty Liver Disease and Metabolic Syndrome
Kim, D., Touros, A., & Kim, W. (2018). Nonalcoholic Fatty Liver Disease and Metabolic Syndrome. Clinics in Liver Disease, 22(1), 133–40.

Decreasing Mortality and Disease Severity in Hepatitis C Patients Awaiting Liver Transplantation in the United States.
Kwong, A., Kim, W., Mannalithara, A., Heo, N.-Y., Udompap, P., & Kim, D. (2017). Decreasing Mortality and Disease Severity in Hepatitis C Patients Awaiting Liver Transplantation in the United States. Liver Transplantation.

Decreasing Mortality and Disease Severity in Hepatitis C Patients Awaiting Liver Transplantation in the United States.
Kwong, A., Kim, W. R., Mannalithara, A., Heo, N.-Y. Y., Udompap, P., & Kim, D. (2017). Decreasing Mortality and Disease Severity in Hepatitis C Patients Awaiting Liver Transplantation in the United States. Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Burden of liver disease in the United States: Summary of a workshop
Kim, W. R., Brown, R. S., Terrault, N. A., & El-Serag, H. (2002). Burden of liver disease in the United States: Summary of a workshop. HEPATOLOGY, 36(1), 227–42.

Liver Simulated Allocation Modeling: Were the Predictions Accurate for Share 35?
Goel, A., Kim, W. R., Pyke, J., Schladt, D. P., Kasiske, B. L., Snyder, J. J., … Israni, A. K. (2018). Liver Simulated Allocation Modeling: Were the Predictions Accurate for Share 35? Transplantation.

Comparing Simultaneous Liver-Kidney Transplant Strategies: A Modified Cost-Effectiveness Analysis.
Cheng, X. S., Kim, W. R., Tan, J. C., Chertow, G. M., & Goldhaber-Fiebert, J. (2018). Comparing Simultaneous Liver-Kidney Transplant Strategies: A Modified Cost-Effectiveness Analysis. Transplantation.

LOWER RISK OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B PATIENTS TREATED WITH ENTECAVIR: A REACH-B ANALYSIS OF THE ENUMERATE STUDY
Ahn, J., Nguyen, M., Lee, H., Lim, J., Pan, C., Te, H., … Kim, W. R. (2015). LOWER RISK OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B PATIENTS TREATED WITH ENTECAVIR: A REACH-B ANALYSIS OF THE ENUMERATE STUDY. JOURNAL OF HEPATOLOGY, 62, S562.

Incidence of Hepatocellular Carcinoma in a National Cohort of Chronic Hepatitis B Patients on Long Term Entecavir Treatment- the ENUMERATE study
Ahn, J., Lim, J. K., Lee, H., Pan, C. Q., Nguyen, M. H., Trinh, H. N., … Kim, W. R. (2014). Incidence of Hepatocellular Carcinoma in a National Cohort of Chronic Hepatitis B Patients on Long Term Entecavir Treatment- the ENUMERATE study. HEPATOLOGY. WILEY-BLACKWELL.

Entecavir Safety and Effectiveness in a National Cohort of Chronic Hepatitis B Patients in the United States - the ENUMERATE study
Ahn, J., Lee, H., Lim, J. K., Pan, C. Q., Nguyen, M. H., Kim, W. R., … Lok, A. S. (2014). Entecavir Safety and Effectiveness in a National Cohort of Chronic Hepatitis B Patients in the United States - the ENUMERATE study. HEPATOLOGY. WILEY-BLACKWELL.

De Novo Hepatocellular Carcinoma Among Liver Transplant Registrants in the Direct Acting Antiviral Era.
Kwong, A. J., Kim, W. R., & Flemming, J. A. (2018). De Novo Hepatocellular Carcinoma Among Liver Transplant Registrants in the Direct Acting Antiviral Era. Hepatology (Baltimore, Md.).

The Use of HCV Positive Donors in HCV Negative Liver Transplant Recipients
Cholankeril, G., Perumpail, R. B., Hu, M., Aggarwal, A., Liu, A., Kwong, A. J., … Ahmed, A. (2016). The Use of HCV Positive Donors in HCV Negative Liver Transplant Recipients. HEPATOLOGY, 64, 807A.

Evolving Demographic Trends in Liver Transplant Waitlist for Primary Biliary Cholangitis
Cholankeril, G., Perumpail, R. B., Yoo, E. R., Hu, M., Kim, W. R., & Ahmed, A. (2016). Evolving Demographic Trends in Liver Transplant Waitlist for Primary Biliary Cholangitis. HEPATOLOGY, 64, 203A–204A.

Predictors of Waitlist Outcomes in Candidates with Primary Biliary Cholangitis awaiting Liver Transplantation
Cholankeril, G., Perumpail, R. B., Wong, R. J., Yoo, E. R., Hu, M., Jayasekera, C. R., … Ahmed, A. (2016). Predictors of Waitlist Outcomes in Candidates with Primary Biliary Cholangitis awaiting Liver Transplantation. HEPATOLOGY. WILEY.

Reduced Survival in Elderly Liver Transplant Recipients: How Old is Too Old?
Heo, N.-Y., Mannalithara, A., Udompap, P., Kim, D., Concepcion, W., Esquivel, C. O., & Kim, W. R. (2015). Reduced Survival in Elderly Liver Transplant Recipients: How Old is Too Old? HEPATOLOGY, 62, 807A.

The Effect of Gastric Acid Suppression on Ledipasivir-Sofosbuvir Effectiveness in Chronic Hepatitis C Infection
Swanner, A., Kumari, R., Garcia, G., Daugherty, T., Nguyen, M. H., Ahmed, A., … Lutchman, G. A. (2016). The Effect of Gastric Acid Suppression on Ledipasivir-Sofosbuvir Effectiveness in Chronic Hepatitis C Infection. HEPATOLOGY, 64, 947A.

Liver Stiffness Measurement, but Not Controlled Attenuation Parameter, is Increased in Deceased Liver Donors at the Time of Transplant Procurement.
Duarte-Rojo, A., Barone, G., Borja-Cacho, D., Concepcion, W., Shaheen, M., Heimbach, J., & Kim, W. (2018). Liver Stiffness Measurement, but Not Controlled Attenuation Parameter, is Increased in Deceased Liver Donors at the Time of Transplant Procurement. AMERICAN JOURNAL OF TRANSPLANTATION, 18, 406.

Rapidly Rising Burden of Portopulmonary Hypertension in the United States
Rahim, U., Mannalithara, A., Kim, D., Zamanian, R., & Kim, W. R. (2017). Rapidly Rising Burden of Portopulmonary Hypertension in the United States. HEPATOLOGY, 66, 253A–254A.

Characteristics of US-Born Versus Foreign-Born Americans of African Descent With Chronic Hepatitis B
Hassan, M. A., Kim, W. R., Li, R., Smith, C. I., Fried, M. W., Sterling, R. K., … Lok, A. S. F. (2017). Characteristics of US-Born Versus Foreign-Born Americans of African Descent With Chronic Hepatitis B. AMERICAN JOURNAL OF EPIDEMIOLOGY, 186(3), 356–66.

Donor Age and Allograft Survival in Recipients with Hepatitis C Virus in the Direct-Acting Antiviral Era
Kwong, A. J., Kim, N. G., Stoltz, D., Mannalithara, A., & Kim, W. R. (2017). Donor Age and Allograft Survival in Recipients with Hepatitis C Virus in the Direct-Acting Antiviral Era. HEPATOLOGY, 66, 886A–887A.

Impact of surveillance for hepatocellular carcinoma on survival in patients with compensated cirrhosis.
Yang, J. D., Mannalithara, A., Piscitello, A. J., Kisiel, J. B., Gores, G. J., Roberts, L. R., & Kim, W. R. (2017). Impact of surveillance for hepatocellular carcinoma on survival in patients with compensated cirrhosis. Hepatology (Baltimore, Md.).

Providing Transplant Candidates with Patient-Specific Public Reports about Programs That Transplant Patients Like Them.
Schaffhausen, C., Bruin, M., Chu, S., Matas, A., Lake, J., Kim, W., … Israni, A. (2018). Providing Transplant Candidates with Patient-Specific Public Reports about Programs That Transplant Patients Like Them. AMERICAN JOURNAL OF TRANSPLANTATION, 18, 739.

OPTN/SRTR 2016 Annual Data Report: Liver
Kim, W. R., Lake, J. R., Smith, J. M., Schladt, D. P., Skeans, M. A., Harper, A. M., … Kasiske, B. L. (2018). OPTN/SRTR 2016 Annual Data Report: Liver. AMERICAN JOURNAL OF TRANSPLANTATION, 18, 172–253.

Is Percent Exception at Transplant a Driver of MELD Inflation?
Schladt, D., Snyder, J., Israni, A., Kim, W., & Lake, J. (2018). Is Percent Exception at Transplant a Driver of MELD Inflation? AMERICAN JOURNAL OF TRANSPLANTATION, 18, 571.

Accepting a DCD Liver May Improve Patient Survival Compared to Waiting for a Non-DCD Liver.
Wey, A., Salkowski, N., Lake, J., Kim, W., Kasiske, B., Israni, A., & Snyder, J. (2018). Accepting a DCD Liver May Improve Patient Survival Compared to Waiting for a Non-DCD Liver. AMERICAN JOURNAL OF TRANSPLANTATION, 18, 382.

Race and Socioeconomic Status Predict Migration for Liver Transplantation in the United States
Kwong, A. J., Mannalithara, A., Heimbach, J., & Kim, W. R. (2017). Race and Socioeconomic Status Predict Migration for Liver Transplantation in the United States. HEPATOLOGY, 66, 306A–307A.

Large Decrease in Liver Waiting List Dropout Rate for MELD > 14.
Schladt, D., Pyke, J., Israni, A., Kim, W., Lake, J., & Snyder, J. (2018). Large Decrease in Liver Waiting List Dropout Rate for MELD > 14. AMERICAN JOURNAL OF TRANSPLANTATION, 18, 567–68.

Calibration of Updated LSAM.
Pyke, J., Weaver, T., Schladt, D., Salkowski, N., Wey, A., Lake, J., … Israni, A. (2018). Calibration of Updated LSAM. AMERICAN JOURNAL OF TRANSPLANTATION, 18, 577–78.

Trajectory of Serum Creatinine in Liver Transplant Candidates Identifies Patients at High Risk of Mortality
Kwong, A. J., Mannalithara, A., Biggins, S. W., Asrani, S. K., Brandman, D., Abt, P. L., … Kim, W. R. (2017). Trajectory of Serum Creatinine in Liver Transplant Candidates Identifies Patients at High Risk of Mortality. HEPATOLOGY, 66, 947A.

A Prognostic Model for Liver Transplant Candidates with Hepatitis C - A Decision Aid for Antiviral Therapy
Lee, H. W., Mannalithara, A., Asrani, S. K., Biggins, S. W., Heimbach, J., Brandman, D., … Kim, W. R. (2017). A Prognostic Model for Liver Transplant Candidates with Hepatitis C - A Decision Aid for Antiviral Therapy. HEPATOLOGY, 66, 548A–549A.

Continued Increase in Incidence of De Novo Hepatocellular Carcinoma Among Liver Transplant Registrants with Hepatitis C Virus Infection
Kwong, A. J., Kim, W. R., & Flemming, J. A. (2017). Continued Increase in Incidence of De Novo Hepatocellular Carcinoma Among Liver Transplant Registrants with Hepatitis C Virus Infection. HEPATOLOGY, 66, 71A.

Providing Transplant Candidates with Guidance about Differences in Acceptance Criteria across Programs.
Schaffhausen, C., Bruin, M., Chu, S., Matas, A., Lake, J., Kim, W., … Israni, A. (2018). Providing Transplant Candidates with Guidance about Differences in Acceptance Criteria across Programs. AMERICAN JOURNAL OF TRANSPLANTATION, 18, 745.

Reduced Incidence of Kidney Waitlisting After Liver Transplantation in the Post-Share 35 Era
Kwong, A. J., Mannalithara, A., Asrani, S. K., Biggins, S. W., Heimbach, J., Brandman, D., … Kim, W. R. (2017). Reduced Incidence of Kidney Waitlisting After Liver Transplantation in the Post-Share 35 Era. HEPATOLOGY, 66, 15A.

Sofosbuvir-based therapy is associated with higher incidence of de-registration for clinical improvement in hepatitis C patients awaiting liver transplantation: Analysis of SRTR-Symphony Database
Kim, W. R., Dellay, B., Wang, J. H., Peng, Y., Sexter, A., & Israni, A. (2017). Sofosbuvir-based therapy is associated with higher incidence of de-registration for clinical improvement in hepatitis C patients awaiting liver transplantation: Analysis of SRTR-Symphony Database. HEPATOLOGY. WILEY.

Exercise and physical activity for patients with end-stage liver disease: Improving functional status and sarcopenia while on the transplant waiting list
Duarte-Rojo, A., Ruiz-Margain, A., Montano-Loza, A. J., Macias-Rodriguez, R. U., Ferrando, A., & Kim, W. R. (2018). Exercise and physical activity for patients with end-stage liver disease: Improving functional status and sarcopenia while on the transplant waiting list. LIVER TRANSPLANTATION, 24(1), 122–39.

Race, Income, and Insurance Status Predict Migration for Liver Transplantation in the United States.
Kwong, A., Mannalithara, A., & Kim, W. (2018). Race, Income, and Insurance Status Predict Migration for Liver Transplantation in the United States. AMERICAN JOURNAL OF TRANSPLANTATION, 18, 308–9.

Characteristics and Costs of NASH Advanced Fibrosis and Cirrhosis in Patients with and without Diabetes Mellitus (DM): Results of a US Real-World Cohort Study
Sanyal, A. J., Bengtson, L., Shreay, S., & Kim, W. R. (2017). Characteristics and Costs of NASH Advanced Fibrosis and Cirrhosis in Patients with and without Diabetes Mellitus (DM): Results of a US Real-World Cohort Study. HEPATOLOGY, 66, 1168A–1169A.

OPTN/SRTR 2015 Annual Data Report: Liver
Kim, W. R., Lake, J. R., Smith, J. M., Skeans, M. A., Schladt, D. P., Edwards, E. B., … Kasiske, B. L. (2017). OPTN/SRTR 2015 Annual Data Report: Liver. AMERICAN JOURNAL OF TRANSPLANTATION, 17, 174–251.

Survival Benefit of Direct Acting Antiviral Therapy in Patients with Decompensated Cirrhosis
Kim, W. R., Mannalithara, A., Lee, H. W., Osinusi, A. O., Schall, R. E. A., & Brainard, D. M. (2017). Survival Benefit of Direct Acting Antiviral Therapy in Patients with Decompensated Cirrhosis. HEPATOLOGY, 66(6), 1270A–1271A.

HCC 6-Month Delay: Comparison of LSAM to Observed
Schladt, D. P., Zeglin, J., Snyder, J., Israni, A., Kim, W. R., & Lake, J. R. (2017). HCC 6-Month Delay: Comparison of LSAM to Observed. HEPATOLOGY, 66, 885A–886A.

Evaluating Displays of Program Waitlist Mortality on Public Search Results.
Schaffhausen, C., Bruin, M., Chu, S., Matas, A., Lake, J., Kim, W., … Israni, A. (2018). Evaluating Displays of Program Waitlist Mortality on Public Search Results. AMERICAN JOURNAL OF TRANSPLANTATION, 18, 741–42.

Is it necessary to screen for varices in cirrhotic patients who are receiving entecavir or tenofovir for chronic hepatitis B?
Wong, V. W., Yip, T. C.-F., Leung, J. C., Wong, J. C., Tse, Y.-K., Kim, W. R., … Wong, G. L. (2017). Is it necessary to screen for varices in cirrhotic patients who are receiving entecavir or tenofovir for chronic hepatitis B? HEPATOLOGY, 66, 249A.

Performance of Donor Risk Index in the MELD era
Kwong, A., & Kim, W. R. (2018). Performance of Donor Risk Index in the MELD era. TRANSPLANTATION, 102, 19.

OPTN/SRTR 2013 Annual Data Report: liver
Kim, W. R., Lake, J. R., Smith, J. M., Skeans, M. A., Schladt, D. P., Edwards, E. B., … Kasiske, B. L. (2015). OPTN/SRTR 2013 Annual Data Report: liver. AMERICAN JOURNAL OF TRANSPLANTATION, 15.

OPTN/SRTR 2012 Annual Data Report: liver
Kim, W. R., Smith, J. M., Skeans, M. A., Schladt, D. P., Schnitzler, M. A., Edwards, E. B., … Kasiske, B. L. (2014). OPTN/SRTR 2012 Annual Data Report: liver. AMERICAN JOURNAL OF TRANSPLANTATION, 14, 69–96.

OPTN/SRTR 2011 Annual Data Report: Liver
Kim, W. R., Stock, P. G., Smith, J. M., Heimbach, J. K., Skeans, M. A., Edwards, E. B., … Kasiske, B. L. (2013). OPTN/SRTR 2011 Annual Data Report: Liver. AMERICAN JOURNAL OF TRANSPLANTATION, 13, 73–102.

Evaluation of Elevated Liver Enzymes
Lee, T. H., Kim, W. R., & Poterucha, J. J. (2012). Evaluation of Elevated Liver Enzymes. CLINICS IN LIVER DISEASE, 16(2), 183-?

Ultrasound-based transient elastography for the detection of hepatic fibrosis in patients with recurrent hepatitis C virus after liver transplantation: A systematic review and meta-analysis
Adebajo, C. O., Talwalkar, J. A., Poterucha, J. J., Kim, W. R., & Charlton, M. R. (2012). Ultrasound-based transient elastography for the detection of hepatic fibrosis in patients with recurrent hepatitis C virus after liver transplantation: A systematic review and meta-analysis. LIVER TRANSPLANTATION, 18(3), 323–31.

Model for End-Stage Liver Disease: End of the First Decade
Asrani, S. K., & Kim, W. R. (2011). Model for End-Stage Liver Disease: End of the First Decade. CLINICS IN LIVER DISEASE, 15(4), 685-?

Drug therapy: Telaprevir
Leise, M. D., Kim, W. R., Canterbury, K. M., & Poterucha, J. J. (2011). Drug therapy: Telaprevir. HEPATOLOGY, 54(4), 1463–69.

Treatment of Hepatitis B Virus-Associated Nephropathy
Elewa, U., Sandri, A. M., Kim, W. R., & Fervenza, F. C. (2011). Treatment of Hepatitis B Virus-Associated Nephropathy. NEPHRON CLINICAL PRACTICE, 119(1), C41–C49.

Report on a single-topic conference on "Chronic viral hepatitis--strategies to improve effectiveness of screening and treatment".
Ward, J. W., Lok, A. S. F., Thomas, D. L., El-Serag, H. B., & Kim, W. R. (2012). Report on a single-topic conference on "Chronic viral hepatitis--strategies to improve effectiveness of screening and treatment". Hepatology , 55(1), 307–15.

Impact of MELD on Waitlist Outcome of Retransplant Candidates
Kim, H. J., Larson, J. J., Lim, Y. S., Kim, W. R., Pedersen, R. A., Therneau, T. M., & Rosen, C. B. (2010). Impact of MELD on Waitlist Outcome of Retransplant Candidates. AMERICAN JOURNAL OF TRANSPLANTATION, 10(12), 2652–57.

Use of Sirolimus in Liver Transplant Recipients with Renal Insufficiency: A Systematic Review and Meta-Analysis
Asrani, S. K., Leise, M. D., West, C. P., Murad, M. H., Pedersen, R. A., Erwin, P. J., … Kim, W. R. (2010). Use of Sirolimus in Liver Transplant Recipients with Renal Insufficiency: A Systematic Review and Meta-Analysis. HEPATOLOGY, 52(4), 1360–70.

Impact of Depressive Symptoms and Their Treatment on Completing Antiviral Treatment in Patients With Chronic Hepatitis C
Liu, S. S., Schneekloth, T. D., Talwalkar, J. A., Kim, W. R., Poterucha, J. J., Charlton, M. R., … Gross, J. B. (2010). Impact of Depressive Symptoms and Their Treatment on Completing Antiviral Treatment in Patients With Chronic Hepatitis C. JOURNAL OF CLINICAL GASTROENTEROLOGY, 44(8), E178–E185.

Rifaximin in hepatic encephalopathy: is an ounce of prevention worth a pretty penny?
Leise, M. D., & Kim, W. R. (2010). Rifaximin in hepatic encephalopathy: is an ounce of prevention worth a pretty penny? Gastroenterology, 139(4), 1416–18.

Daclizumab induction therapy in liver transplant recipients with renal insufficiency
Asrani, S. K., Kim, W. R., Pedersen, R. A., Charlton, M. R., Kremers, W. K., Therneau, T. M., … Dean, P. G. (2010). Daclizumab induction therapy in liver transplant recipients with renal insufficiency. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 32(6), 776–86.

Organ allocation for chronic liver disease: model for end-stage liver disease and beyond
Asrani, S. K., & Kim, W. R. (2010). Organ allocation for chronic liver disease: model for end-stage liver disease and beyond. CURRENT OPINION IN GASTROENTEROLOGY, 26(3), 209–13.

Transforming the current infrastructure for combating HBV and HCV infections
Kim, W. R., Ward, J. W., Cheever, L. W., Dan, C., Dee, L., & Zola, J. (2010). Transforming the current infrastructure for combating HBV and HCV infections. JOURNAL OF FAMILY PRACTICE, 59(4), S65–S70.

Reports from today's health care environment on the implementation of screening, diagnosis, and treatment recommendations
Kim, W. R., Valdiserri, R. O., Wright, L. N., Manos, M. M., & Do, S. T. (2010). Reports from today's health care environment on the implementation of screening, diagnosis, and treatment recommendations. JOURNAL OF FAMILY PRACTICE, 59(4), S43–S49.

Alcoholic Liver Disease-Related Mortality in the United States: 1980-2003
Paula, H., Asrani, S. K., Boetticher, N. C., Pedersen, R., Shah, V. H., & Kim, W. R. (2010). Alcoholic Liver Disease-Related Mortality in the United States: 1980-2003. AMERICAN JOURNAL OF GASTROENTEROLOGY, 105(8), 1782–87.

Hepatitis C Nonresponders: Re-treat or Retreat?
Leise, M., & Kim, W. R. (2009). Hepatitis C Nonresponders: Re-treat or Retreat? HEPATOLOGY, 50(4), 1307–9.

Epidemiology of Hepatitis B in the United States
Kim, W. R. (2009). Epidemiology of Hepatitis B in the United States. HEPATOLOGY, 49(5), S28–S34.

Increased Prevalence and Mortality in Undiagnosed Celiac Disease
Rubio-tapia, A., Kyle, R. A., Kaplan, E. L., Johnson, D. R., Page, W., Erdtmann, F., … Murray, J. A. (2009). Increased Prevalence and Mortality in Undiagnosed Celiac Disease. GASTROENTEROLOGY, 137(1), 88–93.

The International Normalized Ratio of Prothrombin Time in the Model for End-Stage Liver Disease Score: A Reliable Measure
Kamath, P. S. (2009). The International Normalized Ratio of Prothrombin Time in the Model for End-Stage Liver Disease Score: A Reliable Measure. CLINICS IN LIVER DISEASE, 13(1), 63-?

The Global Impact of Hepatic Fibrosis and End-Stage Liver Disease
Lim, Y.-S., & Kim, W. R. (2008). The Global Impact of Hepatic Fibrosis and End-Stage Liver Disease. CLINICS IN LIVER DISEASE, 12(4), 733-?

Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease
Kim, W. R., Flamm, S. L., Di Bisceglie, A. M., & Bodenheimer, H. C. (2008). Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. HEPATOLOGY, 47(4), 1363–70.

Mortality attributable to cholestatic liver disease in the United States
Mendes, F. D., Kim, W. R., Pedersen, R., Therneau, T., & Lindor, K. D. (2008). Mortality attributable to cholestatic liver disease in the United States. HEPATOLOGY, 47(4), 1241–47.

Predictors of early re-bleeding and mortality after acute variceal haemorrhage in patients with cirrhosis
Bambha, K., Kim, W. R., Pedersen, R., Bida, J. P., Kremers, W. K., & Kamath, P. S. (2008). Predictors of early re-bleeding and mortality after acute variceal haemorrhage in patients with cirrhosis. GUT, 57(6), 814–20.

Mortality in patients with hepatitis C.
Pungpapong, S., & Kim, W. R. (2008). Mortality in patients with hepatitis C. Gastroenterology, 134(2), 635–37.

Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease
Stewart, C. A., Malinchoc, M., Kim, W. R., & Kamath, P. S. (2007). Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease. LIVER TRANSPLANTATION, 13(10), 1366–71.

Can the model for end-stage liver disease be used to predict the prognosis in patients with Budd-Chiari syndrome?
Murad, S. D., Kim, W. R., de Groen, P. C., Kamath, P. S., Malinchoc, M., Valla, D.-C., & Janssen, H. la. (2007). Can the model for end-stage liver disease be used to predict the prognosis in patients with Budd-Chiari syndrome? LIVER TRANSPLANTATION, 13(6), 867–74.

Risk factors for mortality after surgery in patients with cirrhosis
Teh, S. H., Nagorney, D. M., Stevens, S. R., Offord, K. P., Therneau, T. M., Plevak, D. J., … Kamath, P. S. (2007). Risk factors for mortality after surgery in patients with cirrhosis. GASTROENTEROLOGY, 132(4), 1261–69.

The Model for End-stage Liver Disease (MELD)
Kamath, P. S., & Kim, W. R. (2007). The Model for End-stage Liver Disease (MELD). HEPATOLOGY, 45(3), 797–805.

Is coffee or tea good for your liver?
Kim, W. R. (2006). Is coffee or tea good for your liver? NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 3(9), 482–83.

Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of end-stage liver disease (MELD) score predicts perioperative mortality
Teh, S. H., Christein, J., Donohue, J., QUE, F., Kendrick, M., Farnell, M., … Nagorney, D. M. (2005). Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of end-stage liver disease (MELD) score predicts perioperative mortality. JOURNAL OF GASTROINTESTINAL SURGERY, 9(9), 1207–15.

Employment and health insurance in long-term liver transplant recipients
Rongey, C., Bambha, K., Vanness, D., Pedersen, R. A., Malinchoc, M., Therneau, T. M., … Kim, W. R. (2005). Employment and health insurance in long-term liver transplant recipients. AMERICAN JOURNAL OF TRANSPLANTATION, 5(8), 1901–8.

The impact of competing risks on the observed rate of chronic hepatitis C progression
Kim, W. R., Poterucha, J. J., Benson, J. T., & Therneau, T. M. (2004). The impact of competing risks on the observed rate of chronic hepatitis C progression. GASTROENTEROLOGY, 127(3), 749–55.

Outcome of liver transplantation for hepatitis B in the United States
Kim, W. R., Poterucha, J. J., Kremers, W. K., Ishitani, M. B., & Dickson, E. R. (2004). Outcome of liver transplantation for hepatitis B in the United States. LIVER TRANSPLANTATION, 10(8), 968–74.

Cost-effectiveness analysis and incremental cost-effectiveness ratios: uses and pitfalls
Bambha, K., & Kim, W. R. (2004). Cost-effectiveness analysis and incremental cost-effectiveness ratios: uses and pitfalls. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 16(6), 519–26.

Primary biliary cirrhosis: an infectious disease caused by Chlamydia pneumoniae?
Abdulkarim, A. S., Petrovic, L. M., Kim, W. R., Angulo, P., Lloyd, R. V., & Lindor, K. D. (2004). Primary biliary cirrhosis: an infectious disease caused by Chlamydia pneumoniae? JOURNAL OF HEPATOLOGY, 40(3), 380–84.

Changing epidemiology of hepatitis B in a US community
Kim, W. R., Benson, J. T., Therneau, T. M., Torgerson, H. A., Yawn, B. P., & Melton, L. J. (2004). Changing epidemiology of hepatitis B in a US community. HEPATOLOGY, 39(3), 811–16.

MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS Status 1 patients
Kremers, W. K., van Ijperen, M., Kim, W. R., Freeman, R. B., Harper, A. M., Kamath, P. S., & Wiesner, R. H. (2004). MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS Status 1 patients. HEPATOLOGY, 39(3), 764–69.

Management of patients with hepatitis C in a community population: Diagnosis, discussions, and decisions to treat
Rocca, L. G., Yawn, B. P., Wollan, P., & Kim, W. R. (2004). Management of patients with hepatitis C in a community population: Diagnosis, discussions, and decisions to treat. ANNALS OF FAMILY MEDICINE, 2(2), 116–24.

Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community
Bambha, K., Kim, W. R., Talwalkar, J., Torgerson, H., Benson, J. T., Therneau, T. M., … Melton, L. J. (2003). Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. GASTROENTEROLOGY, 125(5), 1364–69.

Spontaneous bacterial peritonitis in asymptomatic outpatients with cirrhotic ascites
Evans, L. T., Kim, W. R., Poterucha, J. J., & Kamath, P. S. (2003). Spontaneous bacterial peritonitis in asymptomatic outpatients with cirrhotic ascites. HEPATOLOGY, 37(4), 897–901.

The burden of hepatitis C in the United States
Kim, W. R. (2002). The burden of hepatitis C in the United States. HEPATOLOGY, 36(5), S30–S34.

Global epidemiology and burden of hepatitis C
Kim, W. R. (2002). Global epidemiology and burden of hepatitis C. MICROBES AND INFECTION, 4(12), 1219–25.

Motion - The available treatments for hepatitis C are cost effective: Arguments against the motion
Kim, W. R. (2002). Motion - The available treatments for hepatitis C are cost effective: Arguments against the motion. CANADIAN JOURNAL OF GASTROENTEROLOGY, 16(10), 710–15.

Bayesian estimation, simulation and uncertainty analysis: the cost-effectiveness of ganciclovir prophylaxis in liver transplantation
Vanness, D. J., & Kim, W. R. (2002). Bayesian estimation, simulation and uncertainty analysis: the cost-effectiveness of ganciclovir prophylaxis in liver transplantation. HEALTH ECONOMICS, 11(6), 551–66.

Development and maintenance of a community-based hepatitis C registry
Yawn, B. P., Gazzuola, L., Wollan, P. C., & Kim, W. R. (2002). Development and maintenance of a community-based hepatitis C registry. AMERICAN JOURNAL OF MANAGED CARE, 8(3), 253–61.

Diagnosis and 10-year follow-up of a community-based hepatitis C cohort
Yawn, B. P., Wollan, P., Gazzuola, L., & Kim, W. R. (2002). Diagnosis and 10-year follow-up of a community-based hepatitis C cohort. JOURNAL OF FAMILY PRACTICE, 51(2), 135–40.

MELD and PELD: Application of survival models to liver allocation
Wiesner, R. H., McDiarmid, S. V., Kamath, P. S., Edwards, E. B., Malinchoc, M., Kremers, W. K., … Kim, W. R. (2001). MELD and PELD: Application of survival models to liver allocation. LIVER TRANSPLANTATION, 7(7), 567–80.

A model to predict survival in patients with end-stage liver disease
Kamath, P. S., Wiesner, R. H., Malinchoc, M., Kremers, W., Therneau, T. M., Kosberg, C. L., … Kim, W. R. (2001). A model to predict survival in patients with end-stage liver disease. HEPATOLOGY, 33(2), 464–70.

Outcome of hospital care of liver disease associated with hepatitis C in the United States
Kim, W. R., Gross, J. B., Poterucha, J. J., Locke, G. R., & Dickson, E. R. (2001). Outcome of hospital care of liver disease associated with hepatitis C in the United States. HEPATOLOGY, 33(1), 201–6.

Epidemiology and natural history of primary biliary cirrhosis in a US community
Kim, W. R., Lindor, K. D., Locke, G. R., Therneau, T. M., Homburger, H. A., Batts, K. P., … Dickson, E. R. (2000). Epidemiology and natural history of primary biliary cirrhosis in a US community. GASTROENTEROLOGY, 119(6), 1631–36.

Predicting clinical and economic outcomes after liver transplantation using the Mayo primary sclerosing cholangitis model and Child-Pugh score
Talwalkar, J. A., Seaberg, E., Kim, W. R., & Wiesner, R. H. (2000). Predicting clinical and economic outcomes after liver transplantation using the Mayo primary sclerosing cholangitis model and Child-Pugh score. LIVER TRANSPLANTATION, 6(6), 753–58.

Adaptation of the Mayo primary biliary cirrhosis natural history model for application in liver transplant candidates
Kim, W. R., Wiesner, R. H., Poterucha, J. J., Therneau, T. M., Benson, J. T., Krom, R. A. F., & Dickson, E. R. (2000). Adaptation of the Mayo primary biliary cirrhosis natural history model for application in liver transplant candidates. LIVER TRANSPLANTATION, 6(4), 489–94.

Accuracy of Doppler echocardiography in the assessment of pulmonary hypertension in liver transplant candidates
Kim, W. R., Krowka, M. J., Plevak, D. J., Lee, J., Rettke, S. R., Frantz, R. P., & Wiesner, R. H. (2000). Accuracy of Doppler echocardiography in the assessment of pulmonary hypertension in liver transplant candidates. LIVER TRANSPLANTATION, 6(4), 453–58.

The economic impact of cytomegalovirus infection after liver transplantation
Kim, W. R., Badley, A. D., Wiesner, R. H., Porayko, M. K., Seaberg, E. C., Keating, M. R., … Paya, C. V. (2000). The economic impact of cytomegalovirus infection after liver transplantation. TRANSPLANTATION, 69(3), 357–61.

The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis
Kim, W. R., Poterucha, J. J., Wiesner, R. H., LaRusso, N. F., Lindor, K. D., Petz, J., … Dickson, E. R. (1999). The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis. HEPATOLOGY, 29(6), 1643–48.

The clinical significance of simultaneous infection with hepatitis G virus in patients with chronic hepatitis C
Brandhagen, D. J., Gross, J. B., Poterucha, J. J., Charlton, M. R., Detmer, J., Kolberg, J., … Persing, D. H. (1999). The clinical significance of simultaneous infection with hepatitis G virus in patients with chronic hepatitis C. AMERICAN JOURNAL OF GASTROENTEROLOGY, 94(4), 1000–1005.

Optimal timing of liver transplantation for primary biliary cirrhosis
Kim, W. R., Wiesner, R. H., Therneau, T. M., Poterucha, J. J., Porayko, M. K., Evans, R. W., … Dickson, E. R. (1998). Optimal timing of liver transplantation for primary biliary cirrhosis. HEPATOLOGY, 28(1), 33–38.

Cost-effectiveness of 6 and 12 months of interferon-alpha therapy for chronic hepatitis C
Kim, W. R., Poterucha, J. J., Hermans, J. E., Therneau, T. M., Dickson, E. R., Evans, R. W., & Gross, J. B. (1997). Cost-effectiveness of 6 and 12 months of interferon-alpha therapy for chronic hepatitis C. ANNALS OF INTERNAL MEDICINE, 127(10), 866-?

Recurrence of nonalcoholic steatohepatitis following liver transplantation
Kim, W. R., Poterucha, J. J., Porayko, M. K., Dickson, E. R., Steers, J. L., & Wiesner, R. H. (1996). Recurrence of nonalcoholic steatohepatitis following liver transplantation. TRANSPLANTATION, 62(12), 1802–5.

Timing of liver transplantation
Kim, W. R., & Dickson, E. R. (2000). Timing of liver transplantation. SEMINARS IN LIVER DISEASE, 20(4), 451–64.

Natural History of Primary Biliary Cholangitis in the Ursodeoxycholic Acid Era: Role of Scoring Systems
Goel, A., & Kim, W. R. (2018). Natural History of Primary Biliary Cholangitis in the Ursodeoxycholic Acid Era: Role of Scoring Systems. Clinics in Liver Disease, 22(3).

Emerging Therapies Toward a Functional Cure for Hepatitis B Virus Infection.
Kim, W. R. (2018). Emerging Therapies Toward a Functional Cure for Hepatitis B Virus Infection. Gastroenterology & Hepatology, 14(7), 439–42.

KOREAN VERSION OF A MODEL TO ESTIMATE SURVIVAL IN AMBULATORY PATIENTS WITH HEPATOCELLULAR CARCINOMA (K-MESIAH)
Nam, B. H., Park, J.-W., Jeong, S.-H., Lee, S. S., Yu, A., Kim, B. H., & Kim, W. R. (2015). KOREAN VERSION OF A MODEL TO ESTIMATE SURVIVAL IN AMBULATORY PATIENTS WITH HEPATOCELLULAR CARCINOMA (K-MESIAH). JOURNAL OF HEPATOLOGY, 62, S441.

Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites (vol 62, pg 968, 2015)
Angeli, P., Gines, P., Wong, F., Bernardi, M., Boyer, T. D., Gerbes, A., … Garcia-Tsao, G. (2015). Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites (vol 62, pg 968, 2015). JOURNAL OF HEPATOLOGY, 63(1), 290.

Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites
Angeli, P., Gines, P., Wong, F., Bernardi, M., Boyer, T. D., Gerbes, A., … Garcia-Tsao, G. (2015). Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. GUT, 64(4), 531–37.

Similar Tolerability and Effectiveness with SMV plus SOF Therapy in Asians and Non-Asians with Chronic Hepatitis C Genotype 1 (CHC-1) but Anemia and Fatigue were Common with SOF plus RBV in Both Groups
Chang, C. Y., Nguyen, N. H., Zhao, C., Lutchman, G. A., Ahmed, A., Daugherty, T., … Nguyen, M. H. (2015). Similar Tolerability and Effectiveness with SMV plus SOF Therapy in Asians and Non-Asians with Chronic Hepatitis C Genotype 1 (CHC-1) but Anemia and Fatigue were Common with SOF plus RBV in Both Groups. HEPATOLOGY, 62, 794A.

IFN and/or RBV-Free Therapy (Rx) with Simeprevir plus Sofosbuvir (SMV plus SOF) was Well-Tolerated and Effective for Chronic Hepatitis C Genotype 1 (CHC-1) Including Post-Liver Transplant (LT) and Decompensated Non-Liver Transplant (Non-LT) Patients: A Single-Center Experience
Lutchman, G. A., Nguyen, N. H., Chang, C. Y., Ahmed, A., Daugherty, T., Garcia, G., … Nguyen, M. H. (2015). IFN and/or RBV-Free Therapy (Rx) with Simeprevir plus Sofosbuvir (SMV plus SOF) was Well-Tolerated and Effective for Chronic Hepatitis C Genotype 1 (CHC-1) Including Post-Liver Transplant (LT) and Decompensated Non-Liver Transplant (Non-LT) Patients: A Single-Center Experience. HEPATOLOGY, 62, 797A–798A.

Safety and Effectiveness of Sofosbuvir (SOF) in Combination with Simeprevir (SIM) or Ribavirin (RBV) for the Treatment of Hepatitis C Virus (HCV) Recurrence after Liver Transplant (LT)
Lutchman, G. A., Nguyen, N. H., Hsiao, T. I., Vu, V. D., Chen, V., Ahmed, A., … Nguyen, M. H. (2014). Safety and Effectiveness of Sofosbuvir (SOF) in Combination with Simeprevir (SIM) or Ribavirin (RBV) for the Treatment of Hepatitis C Virus (HCV) Recurrence after Liver Transplant (LT). HEPATOLOGY, 60, 670A.

A Comparison Between Community and Academic Practices in the USA in the Management of Chronic Hepatitis B Patients Receiving Entecavir: Results of the ENUMERATE Study.
Lee, H. M., Ahn, J., Kim, W. R., Lim, J. K., Nguyen, M., Pan, C. Q., … Lok, A. S. (2018). A Comparison Between Community and Academic Practices in the USA in the Management of Chronic Hepatitis B Patients Receiving Entecavir: Results of the ENUMERATE Study. Digestive Diseases and Sciences.

Risk Prediction Models for Graft Failure after Liver Transplantation: A Machine-Learning Approach
Kwong, A. J., O'Connell, C., Kanzawa, M., Hufker, K., Lindsay, N., & Kim, W. R. (2018). Risk Prediction Models for Graft Failure after Liver Transplantation: A Machine-Learning Approach. HEPATOLOGY, 68, 668A–669A.

Refit and Validation of Peld Score
Schladt, D., Wey, A., Herreid, A., Pyke, J., Weaver, T., Snyder, J., … Lake, J. R. (2018). Refit and Validation of Peld Score. HEPATOLOGY, 68, 762A–763A.

Prediction of Mortality Risk in Decompensated Cirrhosis Due to Primary Biliary Cholangitis
Kwong, A. J., Goel, A., Mannalithara, A., Iloeje, U., Feng, C., & Kim, W. R. (2018). Prediction of Mortality Risk in Decompensated Cirrhosis Due to Primary Biliary Cholangitis. HEPATOLOGY, 68, 1098A–1099A.

Providing Liver Transplant Candidates with Patient-Friendly Reports about Transplant Programs
Schaffhausen, C., Bruin, M., Chu, S., Matas, A., Lake, J. R., Kim, W. R., … Israni, A. (2018). Providing Liver Transplant Candidates with Patient-Friendly Reports about Transplant Programs. HEPATOLOGY, 68, 315A.

Treatment of Hepatitis B in the Us; Real-World Evidence from the Trio Network
Bae, H., Curry, M. P., Dieterich, D. T., Ankoma-Sey, V., Reddy, K. R., Pan, C. Q., … Afdhal, N. H. (2018). Treatment of Hepatitis B in the Us; Real-World Evidence from the Trio Network. HEPATOLOGY, 68, 264A–265A.

Patient Reported Indicators of Health and Symptoms in US Patients with Primary Biliary Cholangitis (PBC)
Carey, E. J., Levy, C., Mayo, M. J., Bowlus, C. L., Deane, K., Sandefur, R. A., … Kim, W. R. (2018). Patient Reported Indicators of Health and Symptoms in US Patients with Primary Biliary Cholangitis (PBC). HEPATOLOGY, 68, 1107A–1108A.

Early Adoption of Tenofovir Alafenamide (TAF) for Hepatitis B in US Clinical Practice; Real-World Evidence from the Trio Network
Curry, M. P., Bae, H., Dieterich, D. T., Ankoma-Sey, V., Reddy, K. R., Pan, C. Q., … Afdhal, N. H. (2018). Early Adoption of Tenofovir Alafenamide (TAF) for Hepatitis B in US Clinical Practice; Real-World Evidence from the Trio Network. HEPATOLOGY, 68, 252A.

A model for Glomerular filtration Rate Assessment In Liver disease (GRAIL) in the presence of renal dysfunction.
Asrani, S. K., Jennings, L. W., Trotter, J. F., Levitsky, J., Nadim, M. K., Kim, W. R., … Klintmalm, G. (2018). A model for Glomerular filtration Rate Assessment In Liver disease (GRAIL) in the presence of renal dysfunction. Hepatology (Baltimore, Md.).

Longitudinal trends in renal function in chronic hepatitis B patients receiving oral antiviral treatment.
Udompap, P., Kim, D., Ahmed, A., & Kim, W. R. (2018). Longitudinal trends in renal function in chronic hepatitis B patients receiving oral antiviral treatment. Alimentary Pharmacology & Therapeutics.

Diagnosis and Management of Primary Biliary Cholangitis.
Younossi, Z. M., Bernstein, D., Shiffman, M. L., Kwo, P., Kim, W. R., Kowdley, K. V., & Jacobson, I. M. (2018). Diagnosis and Management of Primary Biliary Cholangitis. The American Journal of Gastroenterology.

Hemoglobin A1c Has Suboptimal Performance to Diagnose and Monitor Diabetes Mellitus in Patients with Cirrhosis
Addepally, N. S., George, N., Martinez-Macias, R., Garcia-Saenz-de-Sicilia, M., Kim, W. R., & Duarte-Rojo, A. (2018). Hemoglobin A1c Has Suboptimal Performance to Diagnose and Monitor Diabetes Mellitus in Patients with Cirrhosis. DIGESTIVE DISEASES AND SCIENCES, 63(12), 3498–3508.

A Real-World Observational Cohort of Patients With Primary Biliary Cholangitis: TARGET-Primary Biliary Cholangitis Study Design and Rationale
Levy, C., Bowlus, C. L., Carey, E., Crawford, J. M., Deane, K., Mayo, M. J., … Fried, M. W. (2018). A Real-World Observational Cohort of Patients With Primary Biliary Cholangitis: TARGET-Primary Biliary Cholangitis Study Design and Rationale. HEPATOLOGY COMMUNICATIONS, 2(5), 484–91.

The interaction of nonalcoholic fatty liver disease and smoking on mortality among adults in the United States.
Wijarnpreecha, K., Scribani, M., Kim, D., & Kim, W. R. (2019). The interaction of nonalcoholic fatty liver disease and smoking on mortality among adults in the United States. Liver International : Official Journal of the International Association for the Study of the Liver.

Impact of Sofosbuvir-Based Therapy on Liver Transplant Candidates with Hepatitis C Virus Infection.
Dellay, B., Sexter, A., Wang, J. H., Hess, G. P., Kim, W. R., & Israni, A. K. (2019). Impact of Sofosbuvir-Based Therapy on Liver Transplant Candidates with Hepatitis C Virus Infection. Pharmacotherapy.

OPTN/SRTR 2017 Annual Data Report: Liver.
Kim, W. R., Lake, J. R., Smith, J. M., Schladt, D. P., Skeans, M. A., Noreen, S. M., … Kasiske, B. L. (2019). OPTN/SRTR 2017 Annual Data Report: Liver. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 19 Suppl 2, 184–283.

IMPACT OF CONTINUOUS POSITIVE AIRWAY PRESSURE TREATMENT ON NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA
Kim, D., Mannalithara, A., Udompap, P., Kushida, C., & Kim, W. R. (2016). IMPACT OF CONTINUOUS POSITIVE AIRWAY PRESSURE TREATMENT ON NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA. JOURNAL OF HEPATOLOGY, 64, S479–S480.

Reduced Survival in Elderly Liver Transplant Recipients: How Old is Too Old?
Heo, N.-Y., Mannalithara, A., Udompap, P., Kim, D., Concepcion, W., Esquivel, C. O., & Kim, W. R. (2015). Reduced Survival in Elderly Liver Transplant Recipients: How Old is Too Old? HEPATOLOGY, 62, 807A.

Reduction in Liver Transplant Wait-Listing in the Era of Direct Acting Anti-Viral Therapy
Flemming, J. A., Kim, W. R., Brosgart, C. L., & Terrault, N. (2016). Reduction in Liver Transplant Wait-Listing in the Era of Direct Acting Anti-Viral Therapy. HEPATOLOGY, 64(6), 1133A.

Decreasing Mortality in Hepatitis C Patients Awaiting Liver Transplantation in the Direct Acting Antiviral Era
Kim, D., Kwong, A., Mannalithara, A., Heo, N.-Y., Udompap, P., & Kim, W. R. (2016). Decreasing Mortality in Hepatitis C Patients Awaiting Liver Transplantation in the Direct Acting Antiviral Era. HEPATOLOGY, 64, 29A.

Nonalcoholic Fatty Liver Disease in the Non-obese: Insights from the PIVENS and FLINT Trials
Kim, D., Mannalithara, A., Udompap, P., & Kim, W. R. (2016). Nonalcoholic Fatty Liver Disease in the Non-obese: Insights from the PIVENS and FLINT Trials. HEPATOLOGY, 64, 537A.

Is cirrhosis reversible in patients with hepatitis C and decompensated liver disease? Explant histology in patients with sustained virologic response
Kwong, A., Kim, W. R., & Higgins, J. (2016). Is cirrhosis reversible in patients with hepatitis C and decompensated liver disease? Explant histology in patients with sustained virologic response. HEPATOLOGY, 64, 395A.

A Markov Model for Transplant & Renal Outcomes After Liver & Simultaneous Liver-Kidney Transplants.
Cheng, X., Kim, W., Tan, J., & Goldhaber-Fiebert, J. (2017). A Markov Model for Transplant & Renal Outcomes After Liver & Simultaneous Liver-Kidney Transplants. AMERICAN JOURNAL OF TRANSPLANTATION, 17, 806.

Impact of Antiviral Nucleotide Analogues on Age-Dependent Decline in Renal Function
Udompap, P., Mannalithara, A., Kim, D., & Kim, W. R. (2016). Impact of Antiviral Nucleotide Analogues on Age-Dependent Decline in Renal Function. HEPATOLOGY, 64, 925A–926A.

Determinants of the future burden of hepatocellular carcinoma after eradication of hepatitis C virus among cirrhotic patients
Udompap, P., Mannalithara, A., Kwong, A. J., Kim, D., Dhanasekaran, R., & Kim, W. R. (2017). Determinants of the future burden of hepatocellular carcinoma after eradication of hepatitis C virus among cirrhotic patients. JOURNAL OF HEPATOLOGY, 66(1), S702–S703.

Model for end stage liver disease score dynamics in NASH patients awaiting liver transplantation and waitlist outcomes
Mannalithara, A., Chan, J. L., Hagerty, D., & Kim, W. R. (2017). Model for end stage liver disease score dynamics in NASH patients awaiting liver transplantation and waitlist outcomes. JOURNAL OF HEPATOLOGY, 66(1), S436.

Model for end stage liver disease score dynamics in patients awaiting liver transplantation and waitlist outcomes
Mannalithara, A., Chan, J. L., Hagerty, D., & Kim, W. R. (2017). Model for end stage liver disease score dynamics in patients awaiting liver transplantation and waitlist outcomes. JOURNAL OF HEPATOLOGY, 66(1), S436–S437.

An alternative screening strategy for hepatitis C virus infection among americans not belonging in the baby boomer birth cohort
Udompap, P., Mannalithara, A., Kwong, A. J., Kim, D., & Kim, W. R. (2017). An alternative screening strategy for hepatitis C virus infection among americans not belonging in the baby boomer birth cohort. JOURNAL OF HEPATOLOGY, 66(1), S414.

Change in the trajectory of MELD scores in liver transplant candidates with hepatitis C in the direct acting antiviral era
Kwong, A., Mannalithara, A., Kim, D., & Kim, W. R. (2017). Change in the trajectory of MELD scores in liver transplant candidates with hepatitis C in the direct acting antiviral era. JOURNAL OF HEPATOLOGY, 66(1), S267–S268.

Steatotic donor livers are increasingly used with minimal effect on graft survival
Kwong, A., Mannalithara, A., & Kim, W. R. (2017). Steatotic donor livers are increasingly used with minimal effect on graft survival. JOURNAL OF HEPATOLOGY, 66(1), S41.

A POTENTIAL ROLE OF SEX HORMONES IN THE PROGRESSION OF END STAGE LIVER DISEASE
Udompap, P., Mannalithara, A., Kim, D., & Kim, W. R. (2016). A POTENTIAL ROLE OF SEX HORMONES IN THE PROGRESSION OF END STAGE LIVER DISEASE. JOURNAL OF HEPATOLOGY, 64, S281–S282.

Impact of Proximity MELD/PELD Points on Liver Redistricting Scenarios.
Gentry, S., Pyke, J., Schladt, D., Zeglin, J., Kim, W., Lake, J., … Israni, A. (2016). Impact of Proximity MELD/PELD Points on Liver Redistricting Scenarios. AMERICAN JOURNAL OF TRANSPLANTATION, 16, 358–59.

Utility in Treating Renal Failure in End-Stage Liver Disease with Simultaneous Liver-Kidney Transplantation.
Cheng, X., Stedman, M., Kim, W., & Tan, J. (2016). Utility in Treating Renal Failure in End-Stage Liver Disease with Simultaneous Liver-Kidney Transplantation. AMERICAN JOURNAL OF TRANSPLANTATION, 16, 232–33.

Historical Comparison of Projected and Observed Liver Transplants
Pyke, J., Schladt, D., Kim, W., Leppke, S., Lake, J., Gentry, S., … Snyder, J. (2015). Historical Comparison of Projected and Observed Liver Transplants. AMERICAN JOURNAL OF TRANSPLANTATION, 15.

Evaluating Outcomes in Multi-Organ Liver Transplant Recipients
Snyder, J., Salkowski, N., Zaun, D., Thompson, B., Zeglin, J., Schladt, D., … Kasiske, B. (2015). Evaluating Outcomes in Multi-Organ Liver Transplant Recipients. AMERICAN JOURNAL OF TRANSPLANTATION, 15.

Age-Dependent Decline in Glomerular Filtration Rate: A US Population-Based Study
Udompap, P., Heo, N.-Y., Mannalithara, A., & Kim, W. (2015). Age-Dependent Decline in Glomerular Filtration Rate: A US Population-Based Study. AMERICAN JOURNAL OF TRANSPLANTATION, 15.

Long-term Patient and Graft Survival After Kidney Transplantation in Recipients With Hepatitis C Virus Infection
Heo, N.-Y., Udompap, P., Mannalithara, A., & Kim, W. (2015). Long-term Patient and Graft Survival After Kidney Transplantation in Recipients With Hepatitis C Virus Infection. AMERICAN JOURNAL OF TRANSPLANTATION, 15.

Short Sleep Duration is associated with Nonalcoholic Fatty Liver Disease in US Adults
Kim, D., Kim, H. J., Allen, A. M., Ahmed, A., Heo, N.-Y., Udompap, P., … Kim, W. R. (2015). Short Sleep Duration is associated with Nonalcoholic Fatty Liver Disease in US Adults. HEPATOLOGY, 62, 1258A.

Policy Implications of Disproportionate Burden of Hepatitis C Care for Medicaid Compared to Commercial Payers
Kim, W. R., Reau, N., Shiffman, M. L., Cournand, H., & Hassanein, T. I. (2015). Policy Implications of Disproportionate Burden of Hepatitis C Care for Medicaid Compared to Commercial Payers. HEPATOLOGY, 62, 1092A–1093A.

Characteristics of Incident PBC Patients in a Large US Laboratory Sample
Lindor, K. D., Mayne, T. J., Swanson, H., Shapiro, D., & Kim, W. R. (2015). Characteristics of Incident PBC Patients in a Large US Laboratory Sample. HEPATOLOGY, 62, 489A.

Heat Mapping Incident PBC Patients in a Large US Laboratory Sample
Lindor, K. D., Mayne, T. J., Swanson, H., Shapiro, D., & Kim, W. R. (2015). Heat Mapping Incident PBC Patients in a Large US Laboratory Sample. HEPATOLOGY, 62, 481A–482A.

Etiology-Specific Effect of Diabetes on the Risk of HCC in Patients with Cirrhosis
Yang, J. D., Mohammed, H. A., Gores, G. J., Roberts, L. R., & Kim, W. R. (2015). Etiology-Specific Effect of Diabetes on the Risk of HCC in Patients with Cirrhosis. HEPATOLOGY, 62, 419A.

Increasing Prevalence of Cirrhosis among US Adults with Chronic Hepatitis C Virus Infection: Results from NHANES 1988-1994 and 1999-2012
Udompap, P., Mannalithara, A., Heo, N.-Y., Kim, D., & Kim, W. R. (2015). Increasing Prevalence of Cirrhosis among US Adults with Chronic Hepatitis C Virus Infection: Results from NHANES 1988-1994 and 1999-2012. HEPATOLOGY, 62, 253A.

Clinical Epidemiology of Primary Biliary Cirrhosis based on a Large US Laboratory Database: Incidence and Trends in Serum Alkaline Phosphatase
Kim, W. R., Mayne, T. J., Marmon, T., Shapiro, D., & Lindor, K. D. (2015). Clinical Epidemiology of Primary Biliary Cirrhosis based on a Large US Laboratory Database: Incidence and Trends in Serum Alkaline Phosphatase. HEPATOLOGY, 62, 245A.

Could Share 35 disadvantage women?
Allen, A. M., Heimbach, J., Larson, J. J., Kim, W. R., Kamath, P. S., & Therneau, T. M. (2015). Could Share 35 disadvantage women? HEPATOLOGY, 62, 210A–211A.

LIVER
Kim, W. R., Lake, J. R., Smith, J. M., Skeans, M. A., Schladt, D. P., Edwards, E. B., … Kasiske, B. L. (2016). LIVER. AMERICAN JOURNAL OF TRANSPLANTATION, 16, 69–98.

Healthcare Utilization Related to Hepatitis C: It Is More Than the Virus
Kim, W. R., Reau, N., Shiffman, M., Cournand, H., & Hassanein, T. (2015). Healthcare Utilization Related to Hepatitis C: It Is More Than the Virus. AMERICAN JOURNAL OF GASTROENTEROLOGY, 110, S886–S887.

ADVANCED FIBROSIS IS COMMON IN INDIVIDUALS WHOSE HEPATITIS C HAS NOT BEEN DIAGNOSED: RESULTS FROM THE NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY 2001-2012
Udompap, P., Mannalithara, A., Heo, N.-Y., & Kim, W. R. (2015). ADVANCED FIBROSIS IS COMMON IN INDIVIDUALS WHOSE HEPATITIS C HAS NOT BEEN DIAGNOSED: RESULTS FROM THE NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY 2001-2012. JOURNAL OF HEPATOLOGY, 62, S253–S254.

THE IMPACT OF METABOLIC SYNDROME ON ALT LEVELS AMONG THE LARGE MULTIETHNIC COHORT OF NORTH AMERICAN PATIENTS WITH CHRONIC HEPATITIS B INFECTION ENROLLED IN THE HEPATITIS B RESEARCH NETWORK (HBRN)
Khalili, M., Lombardero, M., Feld, J., Shuhart, M., Chung, R., Terrault, N., … Lok, A. (2015). THE IMPACT OF METABOLIC SYNDROME ON ALT LEVELS AMONG THE LARGE MULTIETHNIC COHORT OF NORTH AMERICAN PATIENTS WITH CHRONIC HEPATITIS B INFECTION ENROLLED IN THE HEPATITIS B RESEARCH NETWORK (HBRN). JOURNAL OF HEPATOLOGY, 62, S729–S730.

HCC RISK SCORES: APPLICATION OF THE CU-HCC, GAG-HCC AND PAGE-B SCORES TO CHRONIC HEPATITIS B (CHB) PATIENTS TREATED WITH TENOFOVIR DISOPROXIL FUMARATE (TDF)
Kim, W. R., Loomba, R., Berg, T., Schall, R. A., Yee, L., Dinh, P., … Marcellin, P. (2015). HCC RISK SCORES: APPLICATION OF THE CU-HCC, GAG-HCC AND PAGE-B SCORES TO CHRONIC HEPATITIS B (CHB) PATIENTS TREATED WITH TENOFOVIR DISOPROXIL FUMARATE (TDF). JOURNAL OF HEPATOLOGY, 62, S561.

LIVER DISEASES UNIQUE TO PREGNANCY - A POPULATION-BASED STUDY
Allen, A. M., Kim, W. R., Rosedahl, J. K., Yawn, B. P., & Hay, J. E. (2014). LIVER DISEASES UNIQUE TO PREGNANCY - A POPULATION-BASED STUDY. JOURNAL OF HEPATOLOGY, 60(1), S510.

APRI AND FIB-4 VS HISTOLOGY IN CHB PATIENTS IN TENOFOVIR DISOPROXIL FUMARATE (TDF) CLINICAL TRIALS
Kim, W. R., Berg, T., Asselah, T., Flisiak, R., Fung, S., Gordon, S., … Marcellin, P. (2014). APRI AND FIB-4 VS HISTOLOGY IN CHB PATIENTS IN TENOFOVIR DISOPROXIL FUMARATE (TDF) CLINICAL TRIALS. JOURNAL OF HEPATOLOGY, 60(1), S288–S289.

PREDICTION OF ALT FLARES IN THE NATURAL HISTORY OF CHRONIC HEPATITIS B INFECTION: A PROSPECTIVE COHORT STUDY FROM THE NIDDK HEPATITIS B RESEARCH NETWORK (HBRN)
Brahmania, M., Brouwer, W. P., Perrillo, R., Kim, W. R., Wong, D., Feld, J., & Janssen, H. (2014). PREDICTION OF ALT FLARES IN THE NATURAL HISTORY OF CHRONIC HEPATITIS B INFECTION: A PROSPECTIVE COHORT STUDY FROM THE NIDDK HEPATITIS B RESEARCH NETWORK (HBRN). JOURNAL OF HEPATOLOGY, 60(1), S283.

Reply to: "Chronic kidney disease (CKD) and NAFLD: Time for awareness and screening''
Allen, A. M., Kim, W. R., Heimbach, J. K., & Rule, A. D. (2015). Reply to: "Chronic kidney disease (CKD) and NAFLD: Time for awareness and screening''. JOURNAL OF HEPATOLOGY, 62(4), 984–85.

Reply to: "Chronic kidney disease after liver transplantation''
Allen, A. M., Kim, W. R., Therneau, T. M., Larson, J. J., Heimbach, J. K., & Rule, A. D. (2015). Reply to: "Chronic kidney disease after liver transplantation''. JOURNAL OF HEPATOLOGY, 62(1), 244–45.

The Economic Burden and Mortality of Patients with Acute on Chronic Liver Failure (ACLF) in the United States
Allen, A. M., Kim, W. R., Moriarty, J. P., Shah, N., & Kamath, P. S. (2014). The Economic Burden and Mortality of Patients with Acute on Chronic Liver Failure (ACLF) in the United States. HEPATOLOGY, 60, 485A.

Serum Lysyl Oxidase Like 2 (sLOXL2) Levels Correlate with Ishak Fibrosis Score and Decrease with Treatment with Tenofovir Disoproxil Fumarate (TDF) in Patients with Chronic Hepatitis B (CHB)
Kim, W. R., Loomba, R., Lal, P., Schall, R. E. A., Johnson, A. D., Bornstein, J. D., … Sanyal, A. J. (2014). Serum Lysyl Oxidase Like 2 (sLOXL2) Levels Correlate with Ishak Fibrosis Score and Decrease with Treatment with Tenofovir Disoproxil Fumarate (TDF) in Patients with Chronic Hepatitis B (CHB). HEPATOLOGY. WILEY-BLACKWELL.

The effect of long-term use of non-selective beta-blocker on the development of acute kidney injury in patients with liver cirrhosis
Kim, S. G., Kim, W. R., Larson, J. J., Kremers, W. K., & Kamath, P. S. (2014). The effect of long-term use of non-selective beta-blocker on the development of acute kidney injury in patients with liver cirrhosis. HEPATOLOGY, 60, 277A–278A.

Striking differences in wait-listing trends between patients with viral hepatitis B and C: implications of effective anti-viral therapy
Flemming, J. A., Kim, W. R., Brosgart, C., & Terrault, N. (2014). Striking differences in wait-listing trends between patients with viral hepatitis B and C: implications of effective anti-viral therapy. HEPATOLOGY, 60, 208A.

Center Variation in Graft Failure Rates Is Larger for Simultaneous Liver Kidney Transplantation Than Liver Transplantation Alone.
Asrani, S. K., Saracino, G., Trotter, J., Nadim, M., Kim, W. R., Jennings, L., & Klintmalm, G. (2014). Center Variation in Graft Failure Rates Is Larger for Simultaneous Liver Kidney Transplantation Than Liver Transplantation Alone. LIVER TRANSPLANTATION, 20, S278.

Tall, Male, and What Else? Disparities in Liver Transplantation Based On Gender and Height
Allen, A., Kim, W., Larson, J., Heimbach, J., & Therneau, T. (2014). Tall, Male, and What Else? Disparities in Liver Transplantation Based On Gender and Height. AMERICAN JOURNAL OF TRANSPLANTATION, 14, 725.

Toward an Improved Definition of Acute-on-Chronic Liver Failure
Jalan, R., Yurdaydin, C., Bajaj, J. S., Acharya, S. K., Arroyo, V., Lin, H.-C., … Kamath, P. S. (2014). Toward an Improved Definition of Acute-on-Chronic Liver Failure. GASTROENTEROLOGY, 147(1), 4–10.

Rising burden of Hepatitis B in the United States should 'the other' virus be forgotten?.
Kim, W. R., Ishitani, M. R., & Dickson, E. R. (2002). Rising burden of Hepatitis B in the United States should 'the other' virus be forgotten?. HEPATOLOGY, 36(4), 222A.

Is it time for mass screening for hepatitis C?
Kim, W. R., & Poterucha, J. J. (2001). Is it time for mass screening for hepatitis C? AMERICAN JOURNAL OF MEDICINE, 111(8), 667–68.

Treatment of hepatitis C cirrhosis using pegylated interferon: Money well spent?.
Kim, W. R., & Poterucha, J. J. (2001). Treatment of hepatitis C cirrhosis using pegylated interferon: Money well spent?. HEPATOLOGY, 34(4), 327A.

Prediction of liver transplant outcome based on pretransplant disease severity: Is there anything better than MELD?
Wiesner, R. H., Kim, W. R., Malinchoc, M., Kamath, P. S., Kremers, W. K., Weinstein, J. S., … Krom, R. A. (2001). Prediction of liver transplant outcome based on pretransplant disease severity: Is there anything better than MELD? HEPATOLOGY, 34(4), 235A.

Determinants of death on liver transplant waiting list: Waiting time, blood group or MELD?
Kim, W. R., Kremers, W. K., Malinchoc, M., Rosen, C. B., & Dickson, E. R. (2001). Determinants of death on liver transplant waiting list: Waiting time, blood group or MELD? HEPATOLOGY, 34(4), 204A.

Does open access to colonoscopy affect its diagnostic yield?
Kim, W. R., Locke, G. R., Evans, R. W., Zinsmeister, A. R., & Gostout, C. J. (1998). Does open access to colonoscopy affect its diagnostic yield? GASTROENTEROLOGY, 114(4), A22–A23.

Liver transplantation for primary sclerosing cholangitis in the 90's: Patient survival and resource utilization.
Kim, W. R., Wiesner, K. H., Therneau, T. M., Malinchoc, M., Krom, R. A., Evans, R. W., … Starzl, T. E. (1998). Liver transplantation for primary sclerosing cholangitis in the 90's: Patient survival and resource utilization. HEPATOLOGY, 28(4), 389A.

Moderate to severe portopulmonary hypertension: Important correlates with Doppler echocardiography in liver transplant candidates.
Kim, W. R., Krowka, M. J., Plevak, D. J., Lee, J. H., Rettke, Frantz, R. F., & Wiesner, R. H. (1998). Moderate to severe portopulmonary hypertension: Important correlates with Doppler echocardiography in liver transplant candidates. HEPATOLOGY, 28(4), 352A.

Cost-effectiveness of interferon/ribavirin treatment among nonresponders to initial interferon therapy for chronic hepatitis C.
Kim, W. R., Poterucha, J. J., Dickson, E. R., & Gross, J. B. (1998). Cost-effectiveness of interferon/ribavirin treatment among nonresponders to initial interferon therapy for chronic hepatitis C. HEPATOLOGY, 28(4), 231A.

Should Helicobacter pylori be eradicated prior to initiation of a proton pump inhibitor for gastroesophageal reflux disease?
Kim, W. R., & Locke, G. R. (1997). Should Helicobacter pylori be eradicated prior to initiation of a proton pump inhibitor for gastroesophageal reflux disease? GASTROENTEROLOGY, 112(4), A22.

Quantifying the role of H-pylori in gastric carcinogenesis: An accelerated failure time model
Kim, W. R., Therneau, T. M., Locke, G. R., & Dickson, E. R. (1996). Quantifying the role of H-pylori in gastric carcinogenesis: An accelerated failure time model. GASTROENTEROLOGY, 110(4), A156.

The Mayo risk score increases rapidly in the terminal phase of primary sclerosing cholangitis
Kim, W. R., Lindor, K. D., Poterucha, J. J., Benson, J. T., Therneau, T. M., & Dickson, E. R. (1998). The Mayo risk score increases rapidly in the terminal phase of primary sclerosing cholangitis. GASTROENTEROLOGY, 114(4), A1274.

MELD dynamics predicts waitlist outcomes in patients awaiting liver transplantation
Kim, B. H., Mannalithara, A., Kwong, A., & Kim, W. R. (2018). MELD dynamics predicts waitlist outcomes in patients awaiting liver transplantation. JOURNAL OF HEPATOLOGY, 68, S381–S382.

Survival benefits of direct-acting antiviral therapy in patients with decompensated hepatitis C cirrhosis
Kim, W. R., Osinusi, A., Mannalithara, A., Schall, R. A., & Brainard, D. (2018). Survival benefits of direct-acting antiviral therapy in patients with decompensated hepatitis C cirrhosis. JOURNAL OF HEPATOLOGY, 68, S84.

Avatrombopag decreases need for platelet transfusion in patients chronic liver disease and thrombocytopenia undergoing medical procedures with low to high associated bleeding risks
Reau, N. S., Sammy, S., Allen, L. F., Aggarwal, K., Vredenburg, M., & Kim, W. R. (2018). Avatrombopag decreases need for platelet transfusion in patients chronic liver disease and thrombocytopenia undergoing medical procedures with low to high associated bleeding risks. JOURNAL OF HEPATOLOGY, 68, S751.

Distinct MELD trajectories in liver transplant candidates with hepatitis C and non-alcoholic steatohepatitis
Kwong, A., Mannalithara, A., & Kim, W. R. (2018). Distinct MELD trajectories in liver transplant candidates with hepatitis C and non-alcoholic steatohepatitis. JOURNAL OF HEPATOLOGY, 68, S715–S716.

Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites.
Angeli, P., Ginès, P., Wong, F., Bernardi, M., Boyer, T. D., Gerbes, A., … Garcia-Tsao, G. (2015). Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. Journal of Hepatology, 62(4), 968–74.

Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis.
Yang, J. D., Mohamed, H. A., Cvinar, J. L., Gores, G. J., Roberts, L. R., & Kim, W. R. (2016). Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis. The American Journal of Gastroenterology, 111(11), 1573–1580.

Natural History of Primary Biliary Cholangitis in the Ursodeoxycholic Acid Era: Role of Scoring Systems.
Goel, A., & Kim, W. R. (2018). Natural History of Primary Biliary Cholangitis in the Ursodeoxycholic Acid Era: Role of Scoring Systems. Clinics in Liver Disease, 22(3), 563–578.

Nonalcoholic Fatty Liver Disease and Metabolic Syndrome.
Kim, D., Touros, A., & Kim, W. R. (2018). Nonalcoholic Fatty Liver Disease and Metabolic Syndrome. Clinics in Liver Disease, 22(1), 133–140.

Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B.
Kim, W. R., Loomba, R., Berg, T., Aguilar Schall, R. E., Yee, L. J., Dinh, P. V., … Marcellin, P. (2015). Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B. Cancer, 121(20), 3631–8.

Association between body size-metabolic phenotype and non-alcoholic steatohepatitis and significant fibrosis
Kim, W., Kim, D., Harrison, S., Younossi, Z., & Ahmed, A. (2019). Association between body size-metabolic phenotype and non-alcoholic steatohepatitis and significant fibrosis. JOURNAL OF HEPATOLOGY. ELSEVIER SCIENCE BV.

Change in lipids: Characteristics and response to obeticholic acid in TARGET-PBC, a diverse, large United States real-world cohort
Levy, C., Mayo, M. J., Carey, E., Little, E., Kim, W. R., Deane, K., … Bowlus, C. (2019). Change in lipids: Characteristics and response to obeticholic acid in TARGET-PBC, a diverse, large United States real-world cohort. JOURNAL OF HEPATOLOGY, 70, E400.

Effectiveness and safety with tenofovir alafenamide (TAF) for hepatitis B in US clinical practice
Curry, M., Bae, H., Dieterich, D., Ankoma-Sey, V., Reddy, R., Pan, C., … Afdhal, N. (2019). Effectiveness and safety with tenofovir alafenamide (TAF) for hepatitis B in US clinical practice. JOURNAL OF HEPATOLOGY, 70, E462.

Latent trajectory analysis of serum creatinine in patients with end stage liver disease: Predictors of pre- and post-transplant outcomes
Kim, W. R., Asrani, S., Biggins, S., Sripongpun, P., & Mannalithara, A. (2019). Latent trajectory analysis of serum creatinine in patients with end stage liver disease: Predictors of pre- and post-transplant outcomes. JOURNAL OF HEPATOLOGY, 70, E562–E563.

Primary biliary cholangitis-Autoimmune hepatitis overlap syndrome: Characteristics and response to obeticholic acid in TARGET-PBC, a diverse, large United States real-world cohort
Mayo, M. J., Bowlus, C., Carey, E., Little, E., Deane, K., Zink, R., … Levy, C. (2019). Primary biliary cholangitis-Autoimmune hepatitis overlap syndrome: Characteristics and response to obeticholic acid in TARGET-PBC, a diverse, large United States real-world cohort. JOURNAL OF HEPATOLOGY, 70, E403.

Changing Trends in Etiology-Based and Ethnicity-Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the United States
Kim, D., Li, A. A., Perumpail, B. J., Gadiparthi, C., Kim, W., Cholankeril, G., … Ahmed, A. (2019). Changing Trends in Etiology-Based and Ethnicity-Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the United States. HEPATOLOGY, 69(3), 1064–74.

Comparing Simultaneous Liver-Kidney Transplant Strategies: A Modified Cost-Effectiveness Analysis
Cheng, X. S., Kim, W. R., Tan, J. C., Chertow, G. M., & Goldhaber-Fiebert, J. (2018). Comparing Simultaneous Liver-Kidney Transplant Strategies: A Modified Cost-Effectiveness Analysis. TRANSPLANTATION, 102(5), E219–E228.

Diagnosis and Management of Primary Biliary Cholangitis
Younossi, Z. M., Bernstein, D., Shiffman, M. L., Kwo, P., Kim, W. R., Kowdley, K. V., & Jacobson, I. M. (2019). Diagnosis and Management of Primary Biliary Cholangitis. AMERICAN JOURNAL OF GASTROENTEROLOGY, 114(1), 48–63.

Migration of Patients for Liver Transplantation and Waitlist Outcomes.
Kwong, A. J., Mannalithara, A., Heimbach, J., Prentice, M. A., & Kim, W. R. (2019). Migration of Patients for Liver Transplantation and Waitlist Outcomes. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Longitudinal trends in renal function in chronic hepatitis B patients receiving oral antiviral treatment
Udompap, P., Kim, D., Ahmed, A., & Kim, W. R. (2018). Longitudinal trends in renal function in chronic hepatitis B patients receiving oral antiviral treatment. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 48(11-12), 1282–89.

A Model for Glomerular Filtration Rate Assessment in Liver Disease (GRAIL) in the Presence of Renal Dysfunction
Asrani, S. K., Jennings, L. W., Trotter, J. F., Levitsky, J., Nadim, M. K., Kim, W. R., … Klintmalm, G. (2019). A Model for Glomerular Filtration Rate Assessment in Liver Disease (GRAIL) in the Presence of Renal Dysfunction. HEPATOLOGY, 69(3), 1219–30.

A Comparison Between Community and Academic Practices in the USA in the Management of Chronic Hepatitis B Patients Receiving Entecavir: Results of the ENUMERATE Study
Lee, H. M., Ahn, J., Kim, W. R., Lim, J. K., Nguyen, M., Pan, C. Q., … Lok, A. S. (2019). A Comparison Between Community and Academic Practices in the USA in the Management of Chronic Hepatitis B Patients Receiving Entecavir: Results of the ENUMERATE Study. DIGESTIVE DISEASES AND SCIENCES, 64(2), 358–66.

Impact of direct-acting antiviral agents-induced SVR on the long-term burden of hepatocellular carcinoma in chronic hepatitis C cirrhosis.
Udompap, P., Mannalithara, A., Kim, D., & Kim, W. R. (2017). Impact of direct-acting antiviral agents-induced SVR on the long-term burden of hepatocellular carcinoma in chronic hepatitis C cirrhosis. JOURNAL OF CLINICAL ONCOLOGY, 35(4).

De Novo Hepatocellular Carcinoma Among Liver Transplant Registrants in the Direct Acting Antiviral Era
Kwong, A. J., Kim, W. R., & Flemming, J. A. (2018). De Novo Hepatocellular Carcinoma Among Liver Transplant Registrants in the Direct Acting Antiviral Era. HEPATOLOGY, 68(4), 1288–97.

Reduced Access to Liver Transplantation in Women: Role of Height, MELD Exception Scores, and Renal Function Underestimation
Allen, A. M., Heimbach, J. K., Larson, J. J., Mara, K. C., Kim, W. R., Kamath, P. S., & Therneau, T. M. (2018). Reduced Access to Liver Transplantation in Women: Role of Height, MELD Exception Scores, and Renal Function Underestimation. TRANSPLANTATION, 102(10), 1710–16.

Economic analysis of interferon/ribaviran treatment in patients with chronic hepatitis C who relapse following initial interferon therapy
Kim, W. R., Poterucha, J. J., Dickson, E. R., & Gross, J. B. (1998). Economic analysis of interferon/ribaviran treatment in patients with chronic hepatitis C who relapse following initial interferon therapy. GASTROENTEROLOGY, 114(4), A1274.

Defining a willingness-to-transplant threshold in an era of organ scarcity: Simultaneous liver-kidney transplant as a case example.
Cheng, X. S., Goldhaber-Fiebert, J., Tan, J. C., Chertow, G. M., Kim, W. R., & Wall, A. E. (2019). Defining a willingness-to-transplant threshold in an era of organ scarcity: Simultaneous liver-kidney transplant as a case example. Transplantation.

Impact of surveillance for hepatocellular carcinoma on survival in patients with compensated cirrhosis
Yang, J. D., Mannalithara, A., Piscitello, A. J., Kisiel, J. B., Gores, G. J., Roberts, L. R., & Kim, W. R. (2018). Impact of surveillance for hepatocellular carcinoma on survival in patients with compensated cirrhosis. HEPATOLOGY, 68(1), 78–88.

Potential Benefits of Switching Liver Transplant Recipients to Tenofovir Alafenamide Prophylaxis.
Sripongpun, P., Mannalithara, A., Kwo, P. Y., & Kim, W. R. (2019). Potential Benefits of Switching Liver Transplant Recipients to Tenofovir Alafenamide Prophylaxis. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

OPTN/SRTR 2017 Annual Data Report: Liver
Kim, W. R., Lake, J. R., Smith, J. M., Schladt, D. P., Skeans, M. A., Noreen, S. M., … Kasiske, B. L. (2019). OPTN/SRTR 2017 Annual Data Report: Liver. AMERICAN JOURNAL OF TRANSPLANTATION, 19.

CLINICAL PRACTICE EXPERIENCE WITH TENOFOVIR ALAFENAMIDE (TAF) FOR TREATMENT OF HEPATITIS B IN THE US
Curry, M., Bae, H., Dieterich, D., Ankoma-Sey, Reddy, R., Pan, C., … Afdhal, N. (2019). CLINICAL PRACTICE EXPERIENCE WITH TENOFOVIR ALAFENAMIDE (TAF) FOR TREATMENT OF HEPATITIS B IN THE US. VALUE IN HEALTH. ELSEVIER SCIENCE INC.

Continuous Distribution: LSAM Simulation Study.
Weaver, T., Salkowski, N., Snyder, J., Schladt, D., Pyke, J., Herreid, A., … Israni, A. (2019). Continuous Distribution: LSAM Simulation Study. AMERICAN JOURNAL OF TRANSPLANTATION, 19, 377.

A Randomized Pilot Trial of Home-Based Physical Activity Plus Dietary Intervention to Improve Physical Function in Patients with Advanced Liver Disease.
Chen, H., Fernando, A. A., White, M. G., Pauly, M., Bartter, T., Dunn, M. A., … Duarte-Rojo, A. (2019). A Randomized Pilot Trial of Home-Based Physical Activity Plus Dietary Intervention to Improve Physical Function in Patients with Advanced Liver Disease. AMERICAN JOURNAL OF TRANSPLANTATION, 19, 717–18.

Liver Waitlist Dropout and Transplant Rates for Metropolitan vs. Non-Metropolitan Candidates.
Schladt, D., Weaver, T., Pyke, J., Herreid, A., Thompson, B., Kasiske, B., … Israni, A. (2019). Liver Waitlist Dropout and Transplant Rates for Metropolitan vs. Non-Metropolitan Candidates. AMERICAN JOURNAL OF TRANSPLANTATION, 19, 1040.

Liver Transplant Centers Select Different Characteristics for Recipients and Deceased Donors: Implications for Patients When Choosing a Center.
Schaffhausen, C. R., Bruin, M. J., Chu, S., Schladt, D., Chinnakotla, S., Lake, J. R., … Israni, A. K. (2019). Liver Transplant Centers Select Different Characteristics for Recipients and Deceased Donors: Implications for Patients When Choosing a Center. AMERICAN JOURNAL OF TRANSPLANTATION, 19, 715.

Liver Circle-Based Allocation: LSAM Modeling Results.
Schladt, D., Weaver, T., Pyke, J., Herreid, A., Thompson, B., Kasiske, B., … Heimbach, J. (2019). Liver Circle-Based Allocation: LSAM Modeling Results. AMERICAN JOURNAL OF TRANSPLANTATION, 19, 1001.

The interaction of nonalcoholic fatty liver disease and smoking on mortality among adults in the United States
Wijarnpreecha, K., Scribani, M., Kim, D., & Kim, W. R. (2019). The interaction of nonalcoholic fatty liver disease and smoking on mortality among adults in the United States. LIVER INTERNATIONAL, 39(7), 1202–6.

Association between body size-metabolic phenotype and nonalcoholic steatohepatitis and significant fibrosis.
Kim, D., Kim, W., Joo, S. K., Han, J., Kim, J. H., Harrison, S. A., … Ahmed, A. (2019). Association between body size-metabolic phenotype and nonalcoholic steatohepatitis and significant fibrosis. Journal of Gastroenterology.

MELD-GRAIL-Na: Glomerular filtration rate and mortality on Liver-Transplant Waiting List.
Asrani, S. K., Jennings, L. W., Kim, W. R., Kamath, P., Levitsky, J., Nadim, M. K., … Klintmalm, G. (2019). MELD-GRAIL-Na: Glomerular filtration rate and mortality on Liver-Transplant Waiting List. Hepatology (Baltimore, Md.).

Trends in hospitalizations for chronic liver disease-related liver failure in the United States, 2005-2014
Kim, D., Cholankeril, G., Li, A. A., Kim, W., Tighe, S. P., Hameed, B., … Ahmed, A. (2019). Trends in hospitalizations for chronic liver disease-related liver failure in the United States, 2005-2014. LIVER INTERNATIONAL, 39(9), 1661–71.

Migration of Patients for Liver Transplantation and Waitlist Outcomes
Kwong, A. J., Mannalithara, A., Heimbach, J., Prentice, M. A., & Kim, W. R. (2019). Migration of Patients for Liver Transplantation and Waitlist Outcomes. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 17(11), 2347-+.

THE ROLE OF LOCOREGIONAL THERAPY (LRT), POST LRT IMAGING, AND EXPLANT PATHOLOGY AS PREDICTORS OF HEPATOCELLULAR CARCINOMA (HCC) RECURRENCE POST ORTHOTOPIC LIVER TRANSPLANT (OLT)
Prabhakar, V., Dhanasekaran, R., Arjunan, V., Tulu, Z., Ahmed, A., Daugherty, T., … Kwo, P. Y. (2019). THE ROLE OF LOCOREGIONAL THERAPY (LRT), POST LRT IMAGING, AND EXPLANT PATHOLOGY AS PREDICTORS OF HEPATOCELLULAR CARCINOMA (HCC) RECURRENCE POST ORTHOTOPIC LIVER TRANSPLANT (OLT). HEPATOLOGY. WILEY.

FIB-8 SCORE: A MODEL INCORPORATING ADDITIONAL COMMON VARIABLES INTO THE FIB-4 SCORE AFFORDS BETTER PREDICTION OF SIGNIFICANT FIBROSIS IN NONALCOHOLIC FATTY LIVER DISEASE
Sripongpun, P., Mannalithara, A., Kim, D., Touros, A., & Kim, W. R. (2019). FIB-8 SCORE: A MODEL INCORPORATING ADDITIONAL COMMON VARIABLES INTO THE FIB-4 SCORE AFFORDS BETTER PREDICTION OF SIGNIFICANT FIBROSIS IN NONALCOHOLIC FATTY LIVER DISEASE. HEPATOLOGY, 70, 1037A–1038A.

BEYOND THE BIRTH COHORT: STRATEGIES FOR HEPATITIS C SCREENING FOR AMERICANS BORN AFTER 1965
Sripongpun, P., Udompap, P., Mannalithara, A., Kwong, A. J., & Kim, W. R. (2019). BEYOND THE BIRTH COHORT: STRATEGIES FOR HEPATITIS C SCREENING FOR AMERICANS BORN AFTER 1965. HEPATOLOGY, 70, 348A–349A.

DIFFERENTIAL TENOFOVIR ALAFENAMIDE (TAF) ADOPTION IN HBV-INFECTED POPULATIONS; ASSESSMENT OF CARE IN US CLINICAL PRACTICE
Curry, M. P., Bae, H. S., Dieterich, D. T., Ankoma-Sey, V., Reddy, K. R., Pan, C. Q., … Afdhal, N. H. (2019). DIFFERENTIAL TENOFOVIR ALAFENAMIDE (TAF) ADOPTION IN HBV-INFECTED POPULATIONS; ASSESSMENT OF CARE IN US CLINICAL PRACTICE. HEPATOLOGY, 70, 308A–309A.

RISK OF INCIDENT HEPATOCELLULAR CARCINOMA IN HEPATITIS B-INFECTED PATIENTS TREATED WITH TENOFOVIR DISOPROXIL FUMARATE VERSUS ENTECAVIR: A US ADMINISTRATIVE CLAIMS ANALYSIS
Kim, W. R., Telep, L., Lu, M., Ramroth, H., Flaherty, J. F., Gaggar, A., … Gordon, S. C. (2019). RISK OF INCIDENT HEPATOCELLULAR CARCINOMA IN HEPATITIS B-INFECTED PATIENTS TREATED WITH TENOFOVIR DISOPROXIL FUMARATE VERSUS ENTECAVIR: A US ADMINISTRATIVE CLAIMS ANALYSIS. HEPATOLOGY, 70, 302A–303A.

LONGER-TERM EXPERIENCE WITH TENOFOVIR ALAFENAMIDE (TAF) IN HBV-INFECTED PATIENTS; CHANGES IN EGFR, FIB4, ALT, AND DNA SUPPRESSION
Reddy, K. R., Curry, M. P., Bae, H. S., Dieterich, D. T., Ankoma-Sey, V., Pan, C. Q., … Afdhal, N. H. (2019). LONGER-TERM EXPERIENCE WITH TENOFOVIR ALAFENAMIDE (TAF) IN HBV-INFECTED PATIENTS; CHANGES IN EGFR, FIB4, ALT, AND DNA SUPPRESSION. HEPATOLOGY, 70, 309A.

ALBUMIN IS UNDERUTILIZED IN PATIENTS HOSPITALIZED WITH CIRRHOTIC COMPLICATIONS: REAL WORLD EVIDENCE IN THE UNITED STATES
Raghunathan, K., Sindhwani, N., Davis, E. A., Kim, W. R., Telang, S., Runken, M. C., & Lodaya, K. (2019). ALBUMIN IS UNDERUTILIZED IN PATIENTS HOSPITALIZED WITH CIRRHOTIC COMPLICATIONS: REAL WORLD EVIDENCE IN THE UNITED STATES. HEPATOLOGY, 70, 383A.

MORTALITY RISK OF PATIENTS WITH HEPATIC DECOMPENSATION FROM PRIMARY BILIARY CHOLANGITIS IN THE OBETICHOLIC ACID ERA
Mannalithara, A., Kim, W. R., Sripongpun, P., Kwong, A. J., & Goel, A. (2019). MORTALITY RISK OF PATIENTS WITH HEPATIC DECOMPENSATION FROM PRIMARY BILIARY CHOLANGITIS IN THE OBETICHOLIC ACID ERA. HEPATOLOGY. WILEY.

Reply to: "The decreasing predictive power of MELD in an era of changing etiology of liver disease".
Kwong, A., Mannalithara, A., & Kim, W. R. (2019). Reply to: "The decreasing predictive power of MELD in an era of changing etiology of liver disease". American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

USE OF TRANSIENT ELASTOGRAPHY TO ASSESS ALLOGRAFT QUALITY IN DECEASED LIVER DONORS
Duarte-Rojo, A., Heimbach, J., Barone, G. W., Shaheen, M., Lamps, L. W., Rondell, G. P., … Kim, W. R. (2019). USE OF TRANSIENT ELASTOGRAPHY TO ASSESS ALLOGRAFT QUALITY IN DECEASED LIVER DONORS. HEPATOLOGY, 70(6), 1501A.

UPDATES FROM THE 2018 OPTN/SRTR ANNUAL DATA REPORT
Kwong, A. J., Kim, W. R., Lake, J. R., Smith, J., Skeans, M., Snyder, J., & Israni, A. (2019). UPDATES FROM THE 2018 OPTN/SRTR ANNUAL DATA REPORT. HEPATOLOGY, 70(6), 1500A–1501A.

Home-Based Physical Activity and Diet Intervention to Improve Physical Function in Advanced Liver Disease: A Randomized Pilot Trial.
Chen, H. W., Ferrando, A., White, M. G., Dennis, R. A., Xie, J., Pauly, M., … Duarte-Rojo, A. (2020). Home-Based Physical Activity and Diet Intervention to Improve Physical Function in Advanced Liver Disease: A Randomized Pilot Trial. Digestive Diseases and Sciences.

OPTN/SRTR 2018 Annual Data Report: Liver.
Kwong, A., Kim, W. R., Lake, J. R., Smith, J. M., Schladt, D. P., Skeans, M. A., … Kasiske, B. L. (2020). OPTN/SRTR 2018 Annual Data Report: Liver. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 20 Suppl s1, 193–299.

OPTN/SRTR 2018 Annual Data Report: Hepatitis C.
Wang, J. H., Gustafson, S. K., Skeans, M. A., Lake, J. R., Kim, W. R., Kasiske, B. L., … Hart, A. (2020). OPTN/SRTR 2018 Annual Data Report: Hepatitis C. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 20 Suppl s1, 542–68.

Tool to aid patients in selecting a liver transplant center.
Schaffhausen, C. R., Bruin, M. J., Chu, S., Fu, H., McKinney, W. T., Schladt, D., … Israni, A. K. (2020). Tool to aid patients in selecting a liver transplant center. Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Exercise-Induced Hyperammonemia Does Not Precipitate Overt Hepatic Encephalopathy.
Lin, F.-P., Ferrando, A. A., Dennis, R. A., Dunn, M. A., Kim, W. R., & Duarte-Rojo, A. (2020). Exercise-Induced Hyperammonemia Does Not Precipitate Overt Hepatic Encephalopathy. Hepatology (Baltimore, Md.).

Real World Evidence Demonstrates a Difference in the Presenting Characteristics of Cirrhotic Patients Who Received Albumin Compared to Those Who Received Only Crystalloids
Davis, E. A., Kim, W. R., Sindhwani, N. S., Telang, S., Runken, M. C., Lodaya, K., & Raghunathan, K. (2019). Real World Evidence Demonstrates a Difference in the Presenting Characteristics of Cirrhotic Patients Who Received Albumin Compared to Those Who Received Only Crystalloids. AMERICAN JOURNAL OF GASTROENTEROLOGY, 114, S1612.

Cadence from physical activity trackers for monitoring of home-based exercise intensity in advanced liver disease.
Chen, H. W., Ferrando, A. A., Dunn, M. A., Kim, W. R., & Duarte-Rojo, A. (2020). Cadence from physical activity trackers for monitoring of home-based exercise intensity in advanced liver disease. Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Development of Hepatocellular Carcinoma in Patients With Suppressed Viral Replication: Changes in Risk Over Time.
Udompap, P., & Kim, W. R. (2020). Development of Hepatocellular Carcinoma in Patients With Suppressed Viral Replication: Changes in Risk Over Time. Clinical Liver Disease, 15(2), 85–90.

Prevalence of Chronic Hepatitis B Virus Infection in the United States.
Lim, J. K., Nguyen, M. H., Kim, W. R., Gish, R., Perumalswami, P., & Jacobson, I. M. (2020). Prevalence of Chronic Hepatitis B Virus Infection in the United States. The American Journal of Gastroenterology.

HEPATITIS B TREATMENT PATTERNS IN US CLINICAL CARE FOLLOWING TENOFOVIR ALAFENAMIDE (TAF) APPROVAL
Curry, M., Bae, H., Dieterich, D., Ankoma-Sey, Reddy, R., Pan, C., … Afdhal, N. (2020). HEPATITIS B TREATMENT PATTERNS IN US CLINICAL CARE FOLLOWING TENOFOVIR ALAFENAMIDE (TAF) APPROVAL. VALUE IN HEALTH. ELSEVIER SCIENCE INC.

Risk Scores for Hepatocellular Carcinoma in Chronic Hepatitis B: A Promise for Precision Medicine.
Papatheodoridis, G. V., Voulgaris, T., Papatheodoridi, M., & Kim, W. R. (2020). Risk Scores for Hepatocellular Carcinoma in Chronic Hepatitis B: A Promise for Precision Medicine. Hepatology (Baltimore, Md.).

Center variation in intention to treat survival among patients listed for liver transplant.
Kwong, A. J., Flores, A., Saracino, G., Boutte, J., McKenna, G., Giuliano, T., … Asrani, S. K. (2020). Center variation in intention to treat survival among patients listed for liver transplant. Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Cost- Effectiveness of Avatrombopag for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease.
Mladsi, D., Barnett, C., Aggarwal, K., Vredenburg, M., Dieterich, D., & Kim, R. (2020). Cost- Effectiveness of Avatrombopag for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease. ClinicoEconomics and Outcomes Research : CEOR, 12, 515–26.

Introducing the Smartphone App, EL-FIT (Exercise & Liver FITness), to Help Monitor and Prehabilitate Liver Transplant Candidates
Duarte-Rojo, A., Bloomer, P. M., Rogers, R. J., Dunn, M. A., Tapper, E. B., Bataller, R., … Jakicic, J. M. (2020). Introducing the Smartphone App, EL-FIT (Exercise & Liver FITness), to Help Monitor and Prehabilitate Liver Transplant Candidates. AMERICAN JOURNAL OF TRANSPLANTATION, 20, 514.

Creating a Patient Website to Search for Transplant Centers: www. transplantcentersearch.org
Schaffhausen, C. R., Chu, S., Bruin, M., Matas, A., Hertz, M., Martin, C., … Israni, A. K. (2020). Creating a Patient Website to Search for Transplant Centers: www. transplantcentersearch.org. AMERICAN JOURNAL OF TRANSPLANTATION, 20, 555.

National Trends in Locoregional Therapy among Liver Transplant (LT) Candidates with Hepatocellular Carcinoma (HCC) in the United States
Kwong, A., Kim, W., Yao, F., & Mehta, N. (2020). National Trends in Locoregional Therapy among Liver Transplant (LT) Candidates with Hepatocellular Carcinoma (HCC) in the United States. AMERICAN JOURNAL OF TRANSPLANTATION, 20, 490–91.

THE INCIDENCE OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B VIRUS INFECTION SUBJECTS NOT MEETING CRITERIA FOR ANTIVIRAL THERAPY
Alshuwaykh, O., Goel, A., Daugherty, T., Cheung, A., Kim, W. R., Kwong, A. J., … Kwo, P. Y. (2020). THE INCIDENCE OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B VIRUS INFECTION SUBJECTS NOT MEETING CRITERIA FOR ANTIVIRAL THERAPY. HEPATOLOGY. WILEY.

OUTCOMES AFTER HOSPITALIZATION WITH ACUTE DECOMPENSATION DUE TO ALCOHOL-RELATED LIVER DISEASE
Kwong, A. J., Goel, A., Daugherty, T., Kwo, P. Y., & Kim, W. R. (2020). OUTCOMES AFTER HOSPITALIZATION WITH ACUTE DECOMPENSATION DUE TO ALCOHOL-RELATED LIVER DISEASE. HEPATOLOGY. WILEY.

EARLY ALBUMIN INFUSION LEADS TO LOWER HOSPITALIZATION COSTS IN PATIENTS WITH CIRRHOSIS AND SPONTANEOUS BACTERIAL PERITONITIS: REAL EVIDENCE IN THE UNITED STATES
Kim, W. R., Raghunathan, K., Martin, G. S., Davis, E. A., Sindhwani, N., Telang, S., & Lodaya, K. (2020). EARLY ALBUMIN INFUSION LEADS TO LOWER HOSPITALIZATION COSTS IN PATIENTS WITH CIRRHOSIS AND SPONTANEOUS BACTERIAL PERITONITIS: REAL EVIDENCE IN THE UNITED STATES. HEPATOLOGY, 72, 1120.

THE PERVASIVE IMPACT OF PRURITUS ON QUALITY OF LIFE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS (PBC): REAL WORLD EXPERIENCE IN TARGET-PBC
Carey, E. J., Smith, H., McLaughlin, M., Thompson, A., Mospan, A., Sandefur, R. A., … Levy, C. (2020). THE PERVASIVE IMPACT OF PRURITUS ON QUALITY OF LIFE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS (PBC): REAL WORLD EXPERIENCE IN TARGET-PBC. HEPATOLOGY, 72, 766A–767A.

FEASIBILITY AND EFFICACY OF NOREPINEPHRINE IN THE NON-ICU SETTING FOR TREATMENT OF HEPATORENAL SYNDROME
Kwong, A. J., Cheng, X., Kwo, P. Y., Wang, U., & Kim, W. R. (2020). FEASIBILITY AND EFFICACY OF NOREPINEPHRINE IN THE NON-ICU SETTING FOR TREATMENT OF HEPATORENAL SYNDROME. HEPATOLOGY. WILEY.

A MACHINE LEARNING MODEL TO SAFELY TRIAGE LOW-RISK NON-ALCOHOLIC FATTY LIVER DISEASE PATIENTS: THE STEATOSIS-ASSOCIATED FIBROSIS ESTIMATOR (SAFE) SCORE
Sripongpun, P., Mannalithara, A., Kim, D., & Kim, W. R. (2020). A MACHINE LEARNING MODEL TO SAFELY TRIAGE LOW-RISK NON-ALCOHOLIC FATTY LIVER DISEASE PATIENTS: THE STEATOSIS-ASSOCIATED FIBROSIS ESTIMATOR (SAFE) SCORE. HEPATOLOGY, 72, 888A–889A.

MELD 3.0: AN UPDATED VERSION OF THE MODEL FOR END-STAGE LIVER DISEASE TO OPTIMIZE WAITLIST OUTCOMES IN THE MODERN ERA
Kim, W. R., Mannalithara, A., Kamath, P. S., Heimbach, J., Asrani, S. K., Biggins, S. W., & Kwong, A. J. (2020). MELD 3.0: AN UPDATED VERSION OF THE MODEL FOR END-STAGE LIVER DISEASE TO OPTIMIZE WAITLIST OUTCOMES IN THE MODERN ERA. HEPATOLOGY. WILEY.

HEPATITIS C SCREENING IN POST-BABY BOOMER GENERATION AMERICANS: ONE SIZE DOES NOT FIT ALL
Sriponapun, P., Kim, W. R., Udompap, P., Mannalithara, A., Kwong, A. J., Goel, A., & Kwo, P. Y. (2020). HEPATITIS C SCREENING IN POST-BABY BOOMER GENERATION AMERICANS: ONE SIZE DOES NOT FIT ALL. HEPATOLOGY. WILEY.

Tenofovir Alafenamide Attenuates Effects of Diabetes and Body Mass on Serum Alanine Aminotransferase Activities in Patients with Chronic Hepatitis B.
Sripongpun, P., Kim, W. R., Mannalithara, A., Kwong, A., Daugherty, T., Goel, A., & Kwo, P. Y. (2020). Tenofovir Alafenamide Attenuates Effects of Diabetes and Body Mass on Serum Alanine Aminotransferase Activities in Patients with Chronic Hepatitis B. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Introducing EL-FIT (Exercise and Liver FITness): A Smartphone App to Prehabilitate and Monitor Liver Transplant Candidates.
Duarte-Rojo, A., Bloomer, P. M., Rogers, R. J., Hassan, M. A., Dunn, M. A., Tevar, A. D., … Kim, W. R. (2020). Introducing EL-FIT (Exercise and Liver FITness): A Smartphone App to Prehabilitate and Monitor Liver Transplant Candidates. Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Cost-Effectiveness of Avatrombopag for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease
Allen, L. F., Aggarwal, K., Vredenburg, M., Barnett, C., Mladsi, D., & Kim, R. (2019). Cost-Effectiveness of Avatrombopag for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease. BLOOD, 134.

Predictors of Outcomes of Patients Referred to a Transplant Center for Urgent Liver Transplantation Evaluation
Alshuwaykh, O., Kwong, A., Goel, A., Cheung, A., Dhanasekaran, R., Ahmed, A., … Kwo, P. Y. (2020). Predictors of Outcomes of Patients Referred to a Transplant Center for Urgent Liver Transplantation Evaluation. HEPATOLOGY COMMUNICATIONS.

Clinical Response to Treatment for Acute Kidney Injury (AKI) in Patients With Cirrhosis
John, N., Alshuwaykh, O., Goel, A., Ahmed, A., Cheung, A., Dronamraju, D., … Kwo, P. Y. (2020). Clinical Response to Treatment for Acute Kidney Injury (AKI) in Patients With Cirrhosis. AMERICAN JOURNAL OF GASTROENTEROLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Characterizing Ascites in Subjects With Nonhepatic Solid Tumors
Alshuwaykh, O., Cheung, A., Goel, A., Dhanasekaran, R., Ahmed, A., Dronamraju, D., … Kwo, P. Y. (2020). Characterizing Ascites in Subjects With Nonhepatic Solid Tumors. AMERICAN JOURNAL OF GASTROENTEROLOGY. LIPPINCOTT WILLIAMS & WILKINS.

RISK OF INCIDENT HEPATOCELLULAR CARCINOMA (HCC) IN CHRONIC HEPATITIS B (CHB) VIRUS-INFECTED PATIENTS TREATED WITH TENOFOVIR DISOPROXIL FUMARATE (TDF) VERSUS ENTECAVIR (ETV): A US ADMINISTRATIVE CLAIMS ANALYSIS
Kim, R., Telep, L., Lu, M., Ramroth, H., Flaherty, J., Gaggar, A., … Gordon, S. (2020). RISK OF INCIDENT HEPATOCELLULAR CARCINOMA (HCC) IN CHRONIC HEPATITIS B (CHB) VIRUS-INFECTED PATIENTS TREATED WITH TENOFOVIR DISOPROXIL FUMARATE (TDF) VERSUS ENTECAVIR (ETV): A US ADMINISTRATIVE CLAIMS ANALYSIS. GUT, 69, A73.

OPTN/SRTR 2019 Annual Data Report: Liver.
Kwong, A. J., Kim, W. R., Lake, J. R., Smith, J. M., Schladt, D. P., Skeans, M. A., … Kasiske, B. L. (2021). OPTN/SRTR 2019 Annual Data Report: Liver. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 21 Suppl 2, 208–315.

An Updated Assessment of Chronic Hepatitis B Prevalence Among Foreign-Born Persons Living in the United States.
Wong, R. J., Brosgart, C. L., Welch, S., Block, T., Chen, M., Cohen, C., … Gish, R. G. (2021). An Updated Assessment of Chronic Hepatitis B Prevalence Among Foreign-Born Persons Living in the United States. Hepatology (Baltimore, Md.).

Predictors of Outcomes of Patients Referred to a Transplant Center for Urgent Liver Transplantation Evaluation.
Alshuwaykh, O., Kwong, A., Goel, A., Cheung, A., Dhanasekaran, R., Ahmed, A., … Kwo, P. Y. (2021). Predictors of Outcomes of Patients Referred to a Transplant Center for Urgent Liver Transplantation Evaluation. Hepatology Communications, 5(3), 516–525.

Usefulness of Controlled Attenuation Parameter and Liver Stiffness Measurement for the Identification of Extended-criteria Donors and Risk-assessment in Liver Transplantation.
Duarte-Rojo, A., Heimbach, J. K., Borja-Cacho, D., Barone, G. W., Shaheen, M. F., Lamps, L. W., … Kim, W. R. (2021). Usefulness of Controlled Attenuation Parameter and Liver Stiffness Measurement for the Identification of Extended-criteria Donors and Risk-assessment in Liver Transplantation. Transplantation.

Predicting survival after liver transplant: A noble pursuit or a fool's errand?
Kwong, A. J., & Kim, W. R. (2021). Predicting survival after liver transplant: A noble pursuit or a fool's errand? Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Feasibility and Effectiveness of Norepinephrine Outside the Intensive Care Setting for Treatment of Hepatorenal Syndrome.
Kwong, A., Kim, W. R., Kwo, P. Y., Wang, U., & Cheng, X. (2021). Feasibility and Effectiveness of Norepinephrine Outside the Intensive Care Setting for Treatment of Hepatorenal Syndrome. Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Diagnosis, evaluation, and management of ascites and hepatorenal syndrome.
Biggins, S. W., Angeli, P., Garcia-Tsao, G., Gines, P., Ling, S., Nadim, M. K., … Kim, W. R. (2021). Diagnosis, evaluation, and management of ascites and hepatorenal syndrome. Hepatology (Baltimore, Md.).

Overview of Current and Emerging Treatments for Hepatitis B Virus Infection.
Kim, W. R. (2020). Overview of Current and Emerging Treatments for Hepatitis B Virus Infection. Gastroenterology & Hepatology, 16(2), 95–97.

Correcting the sex disparity in access to liver transplantation - Lest perfect be the enemy of better.
Kwong, A. J., Lai, J. C., & Kim, W. R. (2021). Correcting the sex disparity in access to liver transplantation - Lest perfect be the enemy of better. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

MELD 3.0: The Model for End-stage Liver Disease Updated for the Modern Era.
Kim, W. R., Mannalithara, A., Heimbach, J. K., Kamath, P. S., Asrani, S. K., Biggins, S. W., … Kwong, A. J. (2021). MELD 3.0: The Model for End-stage Liver Disease Updated for the Modern Era. Gastroenterology.

Research methodologies to address clinical unmet needs and challenges in alcohol-associated liver disease.
Singal, A. K., Kwo, P., Kwong, A., Liangpunsakul, S., Louvet, A., Mandrekar, P., … Shah, V. H. (2021). Research methodologies to address clinical unmet needs and challenges in alcohol-associated liver disease. Hepatology (Baltimore, Md.).

Methodological Challenges in Meta-Analysis to Assess the Risk of Hepatocellular Carcinoma Across Chronic Hepatitis B Treatments.
Choi, W.-M. M., Yip, T. C.-F., Lim, Y.-S. S., Wong, G. L.-H., & Kim, W. R. (2021). Methodological Challenges in Meta-Analysis to Assess the Risk of Hepatocellular Carcinoma Across Chronic Hepatitis B Treatments. Journal of Hepatology.

Incorporation of Donor Liver Macrovesicular Steatosis Into Srtr Risk Adjustment Models for Deceased Donor Yield and Post-Transplant Outcome
Kwong, A., Wang, C., Wey, A., Salkowski, N., Snyder, J., Wetmore, J., … Kim, W. (2021). Incorporation of Donor Liver Macrovesicular Steatosis Into Srtr Risk Adjustment Models for Deceased Donor Yield and Post-Transplant Outcome. AMERICAN JOURNAL OF TRANSPLANTATION. WILEY.

PREDICTORS OF ELEVATED LIVER TESTS DURING COVID-19 SHELTER IN PLACE IN CHRONIC LIVER DISEASE PATIENTS
Alshuwaykh, O., Wong, R. J., Kim, W. R., Torok, N. J., Jiang, J. K., & Kwo, P. Y. (2021). PREDICTORS OF ELEVATED LIVER TESTS DURING COVID-19 SHELTER IN PLACE IN CHRONIC LIVER DISEASE PATIENTS. HEPATOLOGY. WILEY.

ACCESS TO SUBSPECIALTY CARE FOR PATIENTS WITH ALCOHOL-ASSOCIATED LIVER DISEASE
Kwong, A. J., & Kim, W. R. (2021). ACCESS TO SUBSPECIALTY CARE FOR PATIENTS WITH ALCOHOL-ASSOCIATED LIVER DISEASE. HEPATOLOGY. WILEY.

THE STEATOSIS-ASSOCIATED FIBROSIS ESTIMATOR (SAFE) SCORE: A TOOL FOR PRIMARY CARE TO TRIAGE LOW-RISK NON-ALCOHOLIC FATTY LIVER DISEASE PATIENTS
Sripongpun, P., Mannalithara, A., Kim, D., Kwong, A. J., & Kim, W. R. (2021). THE STEATOSIS-ASSOCIATED FIBROSIS ESTIMATOR (SAFE) SCORE: A TOOL FOR PRIMARY CARE TO TRIAGE LOW-RISK NON-ALCOHOLIC FATTY LIVER DISEASE PATIENTS. HEPATOLOGY. WILEY.

NUMBER OF CHOLANGITIS EPISODES PREDICTS MORTALITY IN PRIMARY SCLEROSING CHOLANGITIS
Kwong, A. J., Sedki, M., Goel, A., & Kim, W. R. (2021). NUMBER OF CHOLANGITIS EPISODES PREDICTS MORTALITY IN PRIMARY SCLEROSING CHOLANGITIS. HEPATOLOGY. WILEY.

HEIGHT AS OPPOSED TO GENDER FOR PREDICTING LIVER TRANSPLANT WAITLIST SURVIVAL IN THE CURRENT ERA
Mannalithara, A., Kwong, A. J., & Kim, W. R. (2021). HEIGHT AS OPPOSED TO GENDER FOR PREDICTING LIVER TRANSPLANT WAITLIST SURVIVAL IN THE CURRENT ERA. HEPATOLOGY. WILEY.

WAITLIST MORTALITY OF DECOMPENSATED PRIMARY BILIARY CHOLANGITIS PATIENTS IN THE OBETICHOLIC ACID ERA
Sedki, M., Kwong, A. J., Mannalithara, A., Goel, A., & Kim, W. R. (2021). WAITLIST MORTALITY OF DECOMPENSATED PRIMARY BILIARY CHOLANGITIS PATIENTS IN THE OBETICHOLIC ACID ERA. HEPATOLOGY. WILEY.

GALLSTONE DISEASE IN THE US: IS THERE AN IMPACT OF OBESITY AND ITS METABOLIC CONSEQUENCES?
Ramphos, E., Mannalithara, A., & Kim, W. R. (2021). GALLSTONE DISEASE IN THE US: IS THERE AN IMPACT OF OBESITY AND ITS METABOLIC CONSEQUENCES? HEPATOLOGY. WILEY.

Predictors of Elevated Liver Tests During COVID-19 Shelter in Place in Those Without Known Liver Disease
Alshuwaykh, O., Wong, R., Jiang, J., Torok, N., & Kim, R. (2021). Predictors of Elevated Liver Tests During COVID-19 Shelter in Place in Those Without Known Liver Disease. AMERICAN JOURNAL OF GASTROENTEROLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Author response to "MELD 3.0: The Model for End-stage Liver Disease Updated for the Modern Era".
Kwong, A., & Kim, W. R. (1800). Author response to "MELD 3.0: The Model for End-stage Liver Disease Updated for the Modern Era". Gastroenterology.

Risk of hepatocellular carcinoma in treatment-naive chronic hepatitis B patients receiving tenofovir disoproxil fumarate versus entecavir in the United States.
Kim, W. R., Telep, L. E., Jump, B., Lu, M., Ramroth, H., Flaherty, J., … Gordon, S. (2022). Risk of hepatocellular carcinoma in treatment-naive chronic hepatitis B patients receiving tenofovir disoproxil fumarate versus entecavir in the United States. Alimentary Pharmacology & Therapeutics.

Cirrhosis Quality Collaborative.
Volk, M. L., Clarke, C., Asrani, S. K., Khaderi, S., Bansal, M. B., Tapper, E. B., … Kanwal, F. (2022). Cirrhosis Quality Collaborative. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association.

Targeted Electronic Patient Portal Messaging Increases Hepatitis C Virus Screening in Primary Care: a Randomized Study.
Halket, D., Dang, J., Phadke, A., Jayasekera, C., Kim, W. R., Kwo, P., … Goel, A. (2022). Targeted Electronic Patient Portal Messaging Increases Hepatitis C Virus Screening in Primary Care: a Randomized Study. Journal of General Internal Medicine.

OPTN/SRTR 2020 Annual Data Report: Liver.
Kwong, A. J., Ebel, N. H., Kim, W. R., Lake, J. R., Smith, J. M., Schladt, D. P., … Kasiske, B. L. (2022). OPTN/SRTR 2020 Annual Data Report: Liver. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 22 Suppl 2, 204–309.

First-line therapies for hepatitis B in the United States: A 3-year prospective and multicenter real-world study after approval of tenofovir alefenamide.
Pan, C. Q., Afdhal, N. H., Ankoma-Sey, V., Bae, H., Curry, M. P., Dieterich, D., … Reddy, K. R. (2022). First-line therapies for hepatitis B in the United States: A 3-year prospective and multicenter real-world study after approval of tenofovir alefenamide. Hepatology Communications.

The steatosis-associated fibrosis estimator (SAFE) score: A tool to detect low-risk non-alcoholic fatty liver disease in primary care.
Sripongpun, P., Kim, W. R., Mannalithara, A., Charu, V., Vidovszky, A., Asch, S., … Kwong, A. J. (2022). The steatosis-associated fibrosis estimator (SAFE) score: A tool to detect low-risk non-alcoholic fatty liver disease in primary care. Hepatology (Baltimore, Md.).

Editorial: risk of hepatocellular carcinoma with tenofovir vs entecavir-A "knock-out" is yet to be delivered-Authors' reply.
Kim, W. R., Telep, L. E., & Chokkalingam, A. P. (2022). Editorial: risk of hepatocellular carcinoma with tenofovir vs entecavir-A "knock-out" is yet to be delivered-Authors' reply. Alimentary Pharmacology & Therapeutics, 55(10), 1344–1345.

TIMELY ALBUMIN INFUSION IS ASSOCIATED WITH A SHORTER HOSPITALIZATION IN CIRRHOTIC PATIENTS
Kim, W. R., Raghunathan, K., Martin, G., Davis, E. A., Sindhwani, N., Blanchette, C., … Lodaya, K. (2022). TIMELY ALBUMIN INFUSION IS ASSOCIATED WITH A SHORTER HOSPITALIZATION IN CIRRHOTIC PATIENTS. CRITICAL CARE MEDICINE. LIPPINCOTT WILLIAMS & WILKINS.

TIMELY ALBUMIN INFUSION MAY IMPROVE SURVIVAL IN CIRRHOTIC PATIENTS: A US CROSS-SECTIONAL STUDY
Kim, W. R., Raghunathan, K., Martin, G., Davis, E. A., Sindhwani, N., Blanchette, C., … Lodaya, K. (2022). TIMELY ALBUMIN INFUSION MAY IMPROVE SURVIVAL IN CIRRHOTIC PATIENTS: A US CROSS-SECTIONAL STUDY. CRITICAL CARE MEDICINE. LIPPINCOTT WILLIAMS & WILKINS.

CIRRHOTIC PATIENTS WITH GREATER BASELINE SEVERITY OF ILLNESS EXPERIENCE HIGHER USE OF TIMELY ALBUMIN
Kim, W. R., Raghunathan, K., Martin, G., Davis, E. A., Sindhwani, N., Blanchette, C., … Lodaya, K. (2022). CIRRHOTIC PATIENTS WITH GREATER BASELINE SEVERITY OF ILLNESS EXPERIENCE HIGHER USE OF TIMELY ALBUMIN. CRITICAL CARE MEDICINE. LIPPINCOTT WILLIAMS & WILKINS.

"Beyond MELD" - Emerging strategies and technologies for improving mortality prediction, organ allocation and outcomes in liver transplantation.
Ge, J., Kim, W. R., Lai, J. C., & Kwong, A. J. (2022). "Beyond MELD" - Emerging strategies and technologies for improving mortality prediction, organ allocation and outcomes in liver transplantation. Journal of Hepatology, 76(6), 1318–1329.

Building a better mousetrap: can MELD-Na be improved?
Kwong, A., Mannalithara, A., Kwo, P., & Kim, W. R. (2020). Building a better mousetrap: can MELD-Na be improved? JOURNAL OF HEPATOLOGY. ELSEVIER.

Barking up the wrong tree: why universal hepatitis C virus screening is not enough for its elimination in the US
Sripongpun, P., Goel, A., Mannalithara, A., Kwo, P., & Kim, W. R. (2020). Barking up the wrong tree: why universal hepatitis C virus screening is not enough for its elimination in the US. JOURNAL OF HEPATOLOGY. ELSEVIER.

Differential tenofovir alafenamide (TAF) adoption in HBV-infected populations; assessment of care in US clinical practice
Curry, M., Bae, H., Dieterich, D., Ankoma-Sey, V., Reddy, R., Pan, C., … Afdhal, N. (2020). Differential tenofovir alafenamide (TAF) adoption in HBV-infected populations; assessment of care in US clinical practice. JOURNAL OF HEPATOLOGY. ELSEVIER.

Longer-term experience with tenofovir alafenamide (TAF) in HBV-infected patients; changes in EGFR, FIB4, ALT, and DNA suppression
Reddy, R., Curry, M., Dieterich, D., Ankoma-Sey, V., Pan, C., Hann, H.-W., … Afdhal, N. (2020). Longer-term experience with tenofovir alafenamide (TAF) in HBV-infected patients; changes in EGFR, FIB4, ALT, and DNA suppression. JOURNAL OF HEPATOLOGY. ELSEVIER.

Impact of Pruritus on Quality of Life and Current Treatment Patterns in Patients with Primary Biliary Cholangitis.
Mayo, M. J., Carey, E., Smith, H. T., Mospan, A. R., McLaughlin, M., Thompson, A., … Levy, C. (2022). Impact of Pruritus on Quality of Life and Current Treatment Patterns in Patients with Primary Biliary Cholangitis. Digestive Diseases and Sciences.

Use of sofosbuvir based direct acting antiviral regimens is associated with reduced mortality in liver transplant candidates with hepatitis C
Wang, J., Sexter, A., Kim, W. R., & Israni, A. (2020). Use of sofosbuvir based direct acting antiviral regimens is associated with reduced mortality in liver transplant candidates with hepatitis C. JOURNAL OF HEPATOLOGY. ELSEVIER.

Comparative risk of hepatocellular carcinoma in patients with chronic hepatitis B receiving tenofovir- or entecavir-based regimens: a meta-analysis using individual patient data
Choi, W.-M., Yip, T. C.-F., Wong, G., Kim, W. R., Yee, L., Brooks-Rooney, C., … Lim, Y.-S. (2022). Comparative risk of hepatocellular carcinoma in patients with chronic hepatitis B receiving tenofovir- or entecavir-based regimens: a meta-analysis using individual patient data. JOURNAL OF HEPATOLOGY. ELSEVIER.

Performance of the Steatosis-Associated Fibrosis Estimator (SAFE) to predict F2 fibrosis and higher in a cohort of South Korean patients with non-alcoholic fatty liver disease (NAFLD)
Charu, V., Kwong, A., Mannalithara, A., Yoon, E., Jun, D. W., & Kim, W. R. (2022). Performance of the Steatosis-Associated Fibrosis Estimator (SAFE) to predict F2 fibrosis and higher in a cohort of South Korean patients with non-alcoholic fatty liver disease (NAFLD). JOURNAL OF HEPATOLOGY. ELSEVIER.

Impact of increasing MELD 3.0 beyond 40 on liver transplant outcomes
Kim, W. R., Mannalithara, A., Tarlow, B., & Kwong, A. (2022). Impact of increasing MELD 3.0 beyond 40 on liver transplant outcomes. JOURNAL OF HEPATOLOGY. ELSEVIER.

Impact of MELD 3.0 Versus MELD-Na in patients with renal dysfunction
Kwong, A., Mannalithara, A., & Kim, W. R. (2022). Impact of MELD 3.0 Versus MELD-Na in patients with renal dysfunction. JOURNAL OF HEPATOLOGY. ELSEVIER.

MELD 3.0 accurately predicts short term survival of patients with end-stage liver disease
Vidovszky, A., Kim, W. R., Kwong, A., & Mannalithara, A. (2022). MELD 3.0 accurately predicts short term survival of patients with end-stage liver disease. JOURNAL OF HEPATOLOGY. ELSEVIER.

EARLY ALBUMIN INFUSION IN CIRRHOTIC PATIENTS WITH SPONTANEOUS BACTERIAL PERITONITIS (SBP) IS ASSOCIATED WITH REDUCTIONS IN TOTAL HOSPITALIZATION COSTS: A CROSS-SECTIONAL STUDY
Viayna, E., Kim, W. R., Raghunathan, K., Martin, G. S., Runken, M. C., & Lodaya, K. (2022). EARLY ALBUMIN INFUSION IN CIRRHOTIC PATIENTS WITH SPONTANEOUS BACTERIAL PERITONITIS (SBP) IS ASSOCIATED WITH REDUCTIONS IN TOTAL HOSPITALIZATION COSTS: A CROSS-SECTIONAL STUDY. VALUE IN HEALTH. ELSEVIER SCIENCE INC.

EARLY ALBUMIN INFUSION MAY REDUCE INTENSIVE CARE UNIT (ICU) COST IN CIRRHOTIC PATIENTS WITH SPONTANEOUS BACTERIAL PERITONITIS (SBP): A CROSS-SECTIONAL STUDY
Runken, M. C., Kim, W. R., Raghunathan, K., Martin, G. S., Viayna, E., & Lodaya, K. (2022). EARLY ALBUMIN INFUSION MAY REDUCE INTENSIVE CARE UNIT (ICU) COST IN CIRRHOTIC PATIENTS WITH SPONTANEOUS BACTERIAL PERITONITIS (SBP): A CROSS-SECTIONAL STUDY. VALUE IN HEALTH. ELSEVIER SCIENCE INC.

Incidence of hepatocellular carcinoma in chronic hepatitis B virus infection in those not meeting criteria for antiviral therapy.
Alshuwaykh, O., Daugherty, T., Cheung, A., Goel, A., Dhanasekaran, R., Ghaziani, T. T., … Kwo, P. Y. (2022). Incidence of hepatocellular carcinoma in chronic hepatitis B virus infection in those not meeting criteria for antiviral therapy. Hepatology Communications.

Impact of Donor Liver Macrovesicular Steatosis on Deceased Donor Yield and Posttransplant Outcome.
Kwong, A. J., Kim, W. R., Lake, J., Stock, P. G., Wang, C. J., Wetmore, J. B., … Israni, A. K. (2022). Impact of Donor Liver Macrovesicular Steatosis on Deceased Donor Yield and Posttransplant Outcome. Transplantation.

Mortality in End Stage Liver Patients Above MELD 3.0 of 40.
Tarlow, B. D., Kim, W. R., Mannalithara, A., Kwo, P. Y., Bonham, C. A., & Kwong, A. (2022). Mortality in End Stage Liver Patients Above MELD 3.0 of 40. Hepatology (Baltimore, Md.).

Clinical characteristics and outcomes in those with primary extrahepatic malignancy and malignant ascites.
Alshuwaykh, O., Cheung, A., Goel, A., Kwong, A., Dhanasekaran, R., Ghaziani, T. T., … Kwo, P. Y. (2022). Clinical characteristics and outcomes in those with primary extrahepatic malignancy and malignant ascites. BMC Gastroenterology, 22(1), 410.

The Model for End-Stage Liver Disease 3.0: An Update Without Proven Accuracy Reply
Kwong, A., & Kim, W. R. (2022). The Model for End-Stage Liver Disease 3.0: An Update Without Proven Accuracy Reply. GASTROENTEROLOGY, 162(6), 1782–1783.

Meld 3.0 for Liver Allocation: Results From the Liver Simulated Allocation Model.
Kwong, A., Weaver, T., Schladt, D., Wey, A., Audette, K., Biggins, S., … Kim, W. (2022). Meld 3.0 for Liver Allocation: Results From the Liver Simulated Allocation Model. AMERICAN JOURNAL OF TRANSPLANTATION. WILEY.

Escalating Waitlist Mortality Above MELD 40: A Rationale to Uncap MELD 3.0?
Kwong, A., Mannalithara, A., & Kim, W. (2022). Escalating Waitlist Mortality Above MELD 40: A Rationale to Uncap MELD 3.0? AMERICAN JOURNAL OF TRANSPLANTATION. WILEY.

Prediction of Waitlist Mortality in Liver Transplant Candidates: Do Time-Varying Models Help?
Kwong, A., Kim, W., Schladt, D., Wey, A., Snyder, J., Israni, A., & Lake, J. (2022). Prediction of Waitlist Mortality in Liver Transplant Candidates: Do Time-Varying Models Help? AMERICAN JOURNAL OF TRANSPLANTATION. WILEY.

Title: On Building a Better Mousetrap Response to: "Towards Optimally Replacing the Current Version of MELD".
Ge, J., Kim, W. R., Lai, J. C., & Kwong, A. J. (2022). Title: On Building a Better Mousetrap Response to: "Towards Optimally Replacing the Current Version of MELD". Journal of Hepatology.

ELEVATED SERUM ALKALINE PHOSPHATASE AS A MARKER OF A DISTINCT PHENOTYPE OF NON-ALCOHOLIC FATTY LIVER DISEASE
Sripongpun, P., Charu, V., Kwo, P. Y., Goel, A., Torok, N. J., & Kim, W. R. (2022). ELEVATED SERUM ALKALINE PHOSPHATASE AS A MARKER OF A DISTINCT PHENOTYPE OF NON-ALCOHOLIC FATTY LIVER DISEASE. HEPATOLOGY. WILEY.

CALIBRATION OF WAITLIST SURVIVAL PREDICTION BY MELD 3.0 IN THE PANDEMIC ERA
Wu, W., Chung, N., Vidovszky, A., Mannalithara, A., Melcher, M., Charu, V., … Kim, W. R. (2022). CALIBRATION OF WAITLIST SURVIVAL PREDICTION BY MELD 3.0 IN THE PANDEMIC ERA. HEPATOLOGY. WILEY.

MELD 3.0 AS A PREDICTOR OF POST-TRANSPLANT OUTCOMES IN THE COVID ERA
Chung, N., Wu, W., Kwong, A. J., Charu, V., Mannalithara, A., Melcher, M., & Kim, W. R. (2022). MELD 3.0 AS A PREDICTOR OF POST-TRANSPLANT OUTCOMES IN THE COVID ERA. HEPATOLOGY. WILEY.

THE WAIST-TO-HIP RATIO ADDS LITTLE TO THE STEATOSIS-ASSOCIATED FIBROSIS ESTIMATOR (SAFE) SCORE IN PREDICTING SIGNIFICANT FIBROSIS AMONG PATIENTS WITH NAFLD
Sripongpun, P., Charu, V., Kim, S. H., & Kim, W. R. (2022). THE WAIST-TO-HIP RATIO ADDS LITTLE TO THE STEATOSIS-ASSOCIATED FIBROSIS ESTIMATOR (SAFE) SCORE IN PREDICTING SIGNIFICANT FIBROSIS AMONG PATIENTS WITH NAFLD. HEPATOLOGY. WILEY.

ACCESS TO SUBSPECIALTY FOLLOW-UP FOR PATIENTS HOSPITALIZED WITH ALCOHOL-ASSOCIATED LIVER DISEASE
Kwong, A. J., Sheira, D., & Kim, W. R. (2022). ACCESS TO SUBSPECIALTY FOLLOW-UP FOR PATIENTS HOSPITALIZED WITH ALCOHOL-ASSOCIATED LIVER DISEASE. HEPATOLOGY. WILEY.

TIMELY ALBUMIN INFUSION MAY IMPROVE SURVIVAL AND LENGTH OF STAY IN PATIENTS WITH CIRRHOSIS AND SPONTANEOUS BACTERIAL PERITONITIS: AN ANALYSIS OF REAL-WORLD EVIDENCE
Ray Kim, W., Raghunathan, K., Martin, G. S., Viayna, E., Rajkumar, R., & Lodaya, K. (2022). TIMELY ALBUMIN INFUSION MAY IMPROVE SURVIVAL AND LENGTH OF STAY IN PATIENTS WITH CIRRHOSIS AND SPONTANEOUS BACTERIAL PERITONITIS: AN ANALYSIS OF REAL-WORLD EVIDENCE. HEPATOLOGY. WILEY.

MELD 3.0 PREDICTS WAITLIST MORTALITY RISK IN ADOLESCENT LIVER TRANSPLANT REGISTRANTS
Kwong, A. J., Zhang, K.-Y., Ebel, N., Mannalithara, A., & Kim, W. R. (2022). MELD 3.0 PREDICTS WAITLIST MORTALITY RISK IN ADOLESCENT LIVER TRANSPLANT REGISTRANTS. HEPATOLOGY. WILEY.

THE EFFECT OF BRANCHED-CHAIN AMINO ACID ON THE IMPROVEMENT OF SERUM ALBUMIN LEVEL IN CIRRHOTIC PATIENTS WITH ASCITES: A MULTI-CENTER, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED TRIAL
Kim, S. G., Seo, Y. S., Jeong, S. W., Kim, M. Y., Park, J. Y., Suk, K. T., … Kim, W. R. (2022). THE EFFECT OF BRANCHED-CHAIN AMINO ACID ON THE IMPROVEMENT OF SERUM ALBUMIN LEVEL IN CIRRHOTIC PATIENTS WITH ASCITES: A MULTI-CENTER, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED TRIAL. HEPATOLOGY. WILEY.

SERIAL STEATOSIS-ASSOCIATED FIBROSIS ESTIMATOR (SAFE) SCORE DETECTS IMPROVEMENT IN FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH)
Sripongpun, P., Mannalithara, A., & Kim, W. R. (2022). SERIAL STEATOSIS-ASSOCIATED FIBROSIS ESTIMATOR (SAFE) SCORE DETECTS IMPROVEMENT IN FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH). HEPATOLOGY. WILEY.

SERUM LIVER FIBROSIS MARKERS PREDICT CNS PALLIDAL ATROPHY
Kwong, A. J., Kim, W. R., & Zahr, N. M. (2022). SERUM LIVER FIBROSIS MARKERS PREDICT CNS PALLIDAL ATROPHY. HEPATOLOGY. WILEY.

TIMELY ALBUMIN INFUSION MAY IMPROVE SURVIVAL AND LENGTH OF STAY IN PATIENTS WITH CIRRHOSIS AND ACUTE KIDNEY INJURY
Kim, W. R., Raghunathan, K., Martin, G. S., Viayna, E., Rajkumar, R., & Lodaya, K. (2022). TIMELY ALBUMIN INFUSION MAY IMPROVE SURVIVAL AND LENGTH OF STAY IN PATIENTS WITH CIRRHOSIS AND ACUTE KIDNEY INJURY. HEPATOLOGY. WILEY.

Hepatocellular carcinoma risk in patients with chronic hepatitis B receiving tenofovir-vs. entecavir-based regimens: individual patient data meta-analysis.
Choi, W.-M., Cheuk-Fung Yip, T., Lai-Hung Wong, G., Kim, W. R., Yee, L. J., Brooks-Rooney, C., … Lim, Y.-S. (2022). Hepatocellular carcinoma risk in patients with chronic hepatitis B receiving tenofovir-vs. entecavir-based regimens: individual patient data meta-analysis. Journal of Hepatology.

MELD 3.0 for adolescent liver transplant candidates.
Kwong, A. J., Zhang, K.-Y. Y., Ebel, N., Mannalithara, A., & Kim, W. R. (2023). MELD 3.0 for adolescent liver transplant candidates. Hepatology (Baltimore, Md.).

Benefits of "The Benefit Model" in liver transplantation
Kim, W. R., & Kremers, W. K. (2008). Benefits of "The Benefit Model" in liver transplantation. HEPATOLOGY, 48(3), 697–698.

Quality of life instruments for liver transplant recipients: Too many choices?
Kim, W. R. (2000). Quality of life instruments for liver transplant recipients: Too many choices? LIVER TRANSPLANTATION, 6(6), 784–785.

Hepatic vein pressure gradient > 10 mm Hg: Prognostic or reflective?
Kim, W. R., & Kamath, P. S. (2008). Hepatic vein pressure gradient > 10 mm Hg: Prognostic or reflective? GASTROENTEROLOGY, 134(2), 641.

The FIB-8 score: validation of a model to screen patients with non-alcoholic fatty liver disease for significant fibrosis
Sripongpun, P., Kim, D., Mannalithara, A., & Kim, W. R. (2020). The FIB-8 score: validation of a model to screen patients with non-alcoholic fatty liver disease for significant fibrosis. JOURNAL OF HEPATOLOGY. ELSEVIER.

Updated estimate for prevalence of chronic hepatitis B among foreign-born persons living in the United States by country of origin
Wong, R., Brosgart, C., Welch, S., Block, T., Chen, M., Cohen, C., … Gish, R. G. (2020). Updated estimate for prevalence of chronic hepatitis B among foreign-born persons living in the United States by country of origin. JOURNAL OF HEPATOLOGY. ELSEVIER.

Early albumin improves survival in cirrhotic patients on diuretic therapy who develop significant acute kidney injury: real-world evidence in the United States
Kim, W. R., Raghunathan, K., Martin, G. S., Davis, E. A., Sindhwani, N., Telang, S., & Lodaya, K. (2020). Early albumin improves survival in cirrhotic patients on diuretic therapy who develop significant acute kidney injury: real-world evidence in the United States. JOURNAL OF HEPATOLOGY. ELSEVIER.

Predictive models in portal hypertension
Garcia-Tsao, G., D'Amico, G., Abraldes, J. G., Schepis, F., Merli, M., Kim, W. R., & Christensen, E. (2006). Predictive models in portal hypertension. PORTAL HYPERTENSION IV. BLACKWELL SCIENCE PUBL.

Epidemiology of Hepatitis B Virus Infection in the United States.
Hyun Kim, B., & Ray Kim, W. (2018). Epidemiology of Hepatitis B Virus Infection in the United States. Clinical Liver Disease, 12(1), 1–4.

Epidemiology of hepatitis B and C in the United States
Asrani, S. K., & Kim, W. R. (2014). Epidemiology of hepatitis B and C in the United States. GI EPIDEMIOLOGY: DISEASES AND CLINICAL METHODOLOGY, 2ND EDITION, 322–331.

A glossary of economic terms
Chiba, N., Gralnek, I. M., Moayyedi, P., Provenzale, D., Inadomi, J. M., Willan, A. R., … Kim, W. R. (2004). A glossary of economic terms. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 16(6), 563–565.

In the Eye of the B-holder: Natural History of Chronic Hepatitis B
Pungpapong, S., & Kim, W. R. (2013). In the Eye of the B-holder: Natural History of Chronic Hepatitis B. HEPATOLOGY, 58(1), 6–8.

The Impact of Timing and Prioritization on the Cost-Effectiveness of Birth Cohort Testing and Treatment for Hepatitis C Virus in the United States
McEwan, P., Ward, T., Yuan, Y., Kim, R., & L'Italien, G. (2013). The Impact of Timing and Prioritization on the Cost-Effectiveness of Birth Cohort Testing and Treatment for Hepatitis C Virus in the United States. HEPATOLOGY, 58(1), 54–64.

Current limits and future challenges in the management of renal dysfunction in patients with cirrhosis: report from the International Club of Ascites
Angeli, P., Sanyal, A., Moller, S., Alessandria, C., Gadano, A., Kim, R., … Bernardi, M. (2013). Current limits and future challenges in the management of renal dysfunction in patients with cirrhosis: report from the International Club of Ascites. LIVER INTERNATIONAL, 33(1), 16–23.

Hepatitis B Screening in a US Academic Primary Care Practice
Loo, N. M., Kim, W. R., Larson, J. J., Wieland, M. L., & Chaudhry, R. (2012). Hepatitis B Screening in a US Academic Primary Care Practice. ARCHIVES OF INTERNAL MEDICINE, 172(19), 1517–1519.

Isoform-specific alanine aminotransferase measurement can distinguish hepatic from extrahepatic injury in humans
Rafter, I., Graberg, T., Kotronen, A., Strommer, L., Mattson, C. M., Kim, R. W., … Glinghammar, B. (2012). Isoform-specific alanine aminotransferase measurement can distinguish hepatic from extrahepatic injury in humans. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 30(5), 1241–1249.

Structural Frameworks and Key Model Parameters in Cost-Effectiveness Analyses for Current and Future Treatments of Chronic Hepatitis C
Townsend, R., McEwan, P., Kim, R., & Yuan, Y. (2011). Structural Frameworks and Key Model Parameters in Cost-Effectiveness Analyses for Current and Future Treatments of Chronic Hepatitis C. VALUE IN HEALTH, 14(8), 1068–1077.

Liver transplantation is effective, but is it cost-effective?
Bambha, K., & Kim, W. R. (2003). Liver transplantation is effective, but is it cost-effective? LIVER TRANSPLANTATION, 9(12), 1308–1311.

Anti-CD25 antibodies (daclizumab) as renal sparing immunosuppression after liver transplantation: authors' reply
Kim, W. R., & Asrani, S. K. (2011). Anti-CD25 antibodies (daclizumab) as renal sparing immunosuppression after liver transplantation: authors' reply. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 33(5), 616–617.

Pretransplantation disease severity and posttransplantation outcome
Kim, W. R. (2003). Pretransplantation disease severity and posttransplantation outcome. LIVER TRANSPLANTATION, 9(2), 124–125.

Is the change in MELD score a better indicator of mortality than baseline MELD score?
Kamath, P. S., & Kim, W. R. (2003). Is the change in MELD score a better indicator of mortality than baseline MELD score? LIVER TRANSPLANTATION, 9(1), 19–21.

Hepatitis B and C
Kim, W. R. (2007). Hepatitis B and C. GI EPIDEMIOLOGY, 254–260.

Race and Receipt of Liver Transplantation: Location Matters
Asrani, S. K., Kim, W. R., & Kamath, P. S. (2010). Race and Receipt of Liver Transplantation: Location Matters. LIVER TRANSPLANTATION, 16(9), 1009–1012.

Efficacy, Effectiveness, and Comparative Effectiveness in Liver Disease
El-Serag, H. B., Talwalkar, J., & Kim, W. R. (2010). Efficacy, Effectiveness, and Comparative Effectiveness in Liver Disease. HEPATOLOGY, 52(2), 403–407.

Clinical implications of short-term variability in liver function test results.
Kim, W. R. (2008). Clinical implications of short-term variability in liver function test results. Gastroenterology, 135(3), 1010.

Survival Benefit of Liver Transplantation: One Size Fits All or Fits None?
Asrani, S. K., Kim, W. R., & Heimbach, J. K. (2009). Survival Benefit of Liver Transplantation: One Size Fits All or Fits None? HEPATOLOGY, 50(2), 352–354.

Hyponatremia in Hepatic Encephalopathy: An Accomplice or Innocent Bystander?
Yun, B. C., & Kim, W. R. (2009). Hyponatremia in Hepatic Encephalopathy: An Accomplice or Innocent Bystander? AMERICAN JOURNAL OF GASTROENTEROLOGY, 104(6), 1390–1391.

The Clip Score: Is it time to be clipped away?
Ray Kim, W. (2009). The Clip Score: Is it time to be clipped away? LIVER INTERNATIONAL, 29(1), 2–3.

Utilization of colonoscopy in the community: A preliminary report.
Kim, W. R., Locke, G. R., Geier, G. R., Zinsmeister, A. R., Melton, L. J., Evans, R. W., & Gostout, C. J. (1997). Utilization of colonoscopy in the community: A preliminary report. GASTROINTESTINAL ENDOSCOPY. MOSBY-YEAR BOOK INC.

What is in a name? toward culturally sensitive nomenclature for liver disease in the east and west.
Kim, W. R., Iwakiri, Y., & Lok, A. S. (2023). What is in a name? toward culturally sensitive nomenclature for liver disease in the east and west. Hepatology (Baltimore, Md.).

Evidence for Benefits of Early Treatment Initiation for Chronic Hepatitis B.
Lim, Y.-S. S., Kim, W. R., Dieterich, D., Kao, J.-H. H., Flaherty, J. F., Yee, L. J., … Kennedy, P. T. (2023). Evidence for Benefits of Early Treatment Initiation for Chronic Hepatitis B. Viruses, 15(4).

OPTN/SRTR 2021 Annual Data Report: Liver.
Kwong, A. J., Ebel, N. H., Kim, W. R., Lake, J. R., Smith, J. M., Schladt, D. P., … Kasiske, B. L. (2023). OPTN/SRTR 2021 Annual Data Report: Liver. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 23(2S1), S178–S263.

OPTN/SRTR 2021 Annual Data Report: Liver
Kwong, A. J., Ebel, N. H., Kim, W. R., Lake, J. R., Smith, J. M., Schladt, D. P., … Kasiske, B. L. (2023). OPTN/SRTR 2021 Annual Data Report: Liver. AMERICAN JOURNAL OF TRANSPLANTATION. ELSEVIER SCIENCE INC.

OPTN/SRTR 2018 Annual Data Report: Kidney
Hart, A., Smith, J. M., Skeans, M. A., Gustafson, S. K., Wilk, A. R., Castro, S., … Israni, A. K. (2020). OPTN/SRTR 2018 Annual Data Report: Kidney. AMERICAN JOURNAL OF TRANSPLANTATION, 20, 340–426.

Correction to: Impact of Pruritus on Quality of Life and Current Treatment Patterns in Patients with Primary Biliary Cholangitis.
Mayo, M. J., Carey, E., Smith, H. T., Mospan, A. R., McLaughlin, M., Thompson, A., … Levy, C. (2023). Correction to: Impact of Pruritus on Quality of Life and Current Treatment Patterns in Patients with Primary Biliary Cholangitis. Digestive Diseases and Sciences.

Benchmarking clinical risk prediction algorithms with ensemble machine learning: An illustration of the superlearner algorithm for the non-invasive diagnosis of liver fibrosis in non-alcoholic fatty liver disease.
Charu, V., Liang, J. W., Mannalithara, A., Kwong, A., Tian, L., & Kim, W. R. (2023). Benchmarking clinical risk prediction algorithms with ensemble machine learning: An illustration of the superlearner algorithm for the non-invasive diagnosis of liver fibrosis in non-alcoholic fatty liver disease. MedRxiv : the Preprint Server for Health Sciences.

Diagnostic and prognostic performance of the SAFE score in non-alcoholic fatty liver disease.
Li, G., Lin, H., Sripongpun, P., Liang, L. Y., Zhang, X., Wong, V. W., … Yip, T. C. (2023). Diagnostic and prognostic performance of the SAFE score in non-alcoholic fatty liver disease. Liver International : Official Journal of the International Association for the Study of the Liver.

Hepatitis C Screening in Post-Baby Boomer Generation Americans: One Size Does Not Fit All.
Sripongpun, P., Udompap, P., Mannalithara, A., Downing, N. L., Vidovszky, A. A., Kwong, A. J., … Kim, W. R. (2023). Hepatitis C Screening in Post-Baby Boomer Generation Americans: One Size Does Not Fit All. Mayo Clinic Proceedings, 98(9), 1335–1344.

Diagnostic and prognostic performance of the SAFE score in nonalcoholic fatty liver disease
Li, G., Lin, H., Sripongpun, P., Liang, Y., Zhang, X., Wong, V. W.-S., … Yip, T. C.-F. (2023). Diagnostic and prognostic performance of the SAFE score in nonalcoholic fatty liver disease. JOURNAL OF HEPATOLOGY. ELSEVIER.

SAFE score yielded a better performance than FIB-4 and NFS in predicting significant fibrosis among Asian NAFLD patients
Sripongpun, P., Treeprasertsuk, S., Charatcharoenwitthaya, P., Kaewdech, A., Chamroonkul, N., Chan, W.-K., … Kim, W. R. (2023). SAFE score yielded a better performance than FIB-4 and NFS in predicting significant fibrosis among Asian NAFLD patients. JOURNAL OF HEPATOLOGY. ELSEVIER.

Who is safe from chronic liver disease? A population-based approach for early detection in the US
Chung, N., Mannalithara, A., Charu, V., & Kim, W. R. (2023). Who is safe from chronic liver disease? A population-based approach for early detection in the US. JOURNAL OF HEPATOLOGY. ELSEVIER.

Alcohol Use in Liver Transplant Recipients With Alcohol-related Liver Disease: A Comparative Assessment of Relapse Prediction Models.
Sedki, M., Kwong, A., Bhargava, M., Ahmed, A., Daugherty, T., Kwo, P., … Goel, A. (2023). Alcohol Use in Liver Transplant Recipients With Alcohol-related Liver Disease: A Comparative Assessment of Relapse Prediction Models. Transplantation.

Racial Disparities in Access to Liver Transplantation in the United States
Kwong, A., Yilma, M., Lake, J., Kim, W., Snyder, J., Israni, A., & Hirose, R. (2023). Racial Disparities in Access to Liver Transplantation in the United States. AMERICAN JOURNAL OF TRANSPLANTATION. ELSEVIER SCIENCE INC.

EXPOSURE TO GLP1RA THERAPY IS ASSOCIATED WITH IMPROVED SURVIVAL IN POST LIVER TRANSPLANT PATIENTS WITH TYPE I I DIABETES MELLITUS
Achalu, S., Berry, R., Manikat, R., Yeoh, A., Gombar, S., Kim, S. H., … Kwo, P. Y. (2023). EXPOSURE TO GLP1RA THERAPY IS ASSOCIATED WITH IMPROVED SURVIVAL IN POST LIVER TRANSPLANT PATIENTS WITH TYPE I I DIABETES MELLITUS. HEPATOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

WE ARE GOING DOWN THE WRONG PATH! THE CURRENT AASLD GUIDANCE MISCLASSIFIES MAJORITY OF PATIENTS WITH MASLD AND SIGNIFICANT FIBROSIS
Kim, W. R., Chung, N. L., Mannalithara, A., Charu, V., Torok, N. J., Kwo, P. Y., … Kim, S. H. (2023). WE ARE GOING DOWN THE WRONG PATH! THE CURRENT AASLD GUIDANCE MISCLASSIFIES MAJORITY OF PATIENTS WITH MASLD AND SIGNIFICANT FIBROSIS. HEPATOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

EMPAGLIFLOZIN IN DIURETIC REFRACTORY ASCITES (DRAIN-EM): RESULTS OF A SINGLE-CENTER FEASIBILITY STUDY
Goel, A., Tarlow, B. D., Kwong, A. J., Hu, K., Cheng, X., Kim, S. H., … Kwo, P. Y. (2023). EMPAGLIFLOZIN IN DIURETIC REFRACTORY ASCITES (DRAIN-EM): RESULTS OF A SINGLE-CENTER FEASIBILITY STUDY. HEPATOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

EARLY ALBUMIN INFUSION MAY IMPROVE OUTCOMES IN MULTIDRUG-RESISTANT ORGANISM INFECTIONS AMONG PATIENTS WITH SPONTANEOUS BACTERIAL PERITONITIS
Kim, W. R., Viayna, E., Ardiles, T., Rajkumar, R., Lodaya, K., & Hwang, S. (2023). EARLY ALBUMIN INFUSION MAY IMPROVE OUTCOMES IN MULTIDRUG-RESISTANT ORGANISM INFECTIONS AMONG PATIENTS WITH SPONTANEOUS BACTERIAL PERITONITIS. HEPATOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

SURVIVAL OF PATIENTS WITH DECOMPENSATED PRIMARY BILIARY CHOLANGITIS IN THE ERA OF OBETICHOLIC ACID AND MELD 3.0
Sedki, M., Chung, N. L., Goel, A., Montano-Loza, A. J., Kwong, A. J., Sasaki, K., … Mannalithara, A. (2023). SURVIVAL OF PATIENTS WITH DECOMPENSATED PRIMARY BILIARY CHOLANGITIS IN THE ERA OF OBETICHOLIC ACID AND MELD 3.0. HEPATOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

PREDICTORS OF RENAL RECOVERY AND SURVIVAL OUTCOMES IN LIVER TRANSPLANT RECIPIENTS MEETING SLK ELIGIBILITY CRITERIA
Manikat, R., Kwong, A. J., Cheng, X., Chow, B., Bhargava, M., Achalu, S., … Kwo, P. Y. (2023). PREDICTORS OF RENAL RECOVERY AND SURVIVAL OUTCOMES IN LIVER TRANSPLANT RECIPIENTS MEETING SLK ELIGIBILITY CRITERIA. HEPATOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

IMPACT OF ETIOLOGY ON THE PREDICTION OF WAITLIST MORTALITY IN LIVER TRANSPLANT CANDIDATES
Chung, N. L., Mannalithara, A., Kim, W. R., & Kwong, A. J. (2023). IMPACT OF ETIOLOGY ON THE PREDICTION OF WAITLIST MORTALITY IN LIVER TRANSPLANT CANDIDATES. HEPATOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

THE UTILITY OF SEQUENTIAL SAFE SCORE AND FIBROSCAN IN PREDICTING CLINICALLY SIGNIFICANT FIBROSIS IN ASIAN NAFLD PATIENTS.
Sripongpun, P., Treeprasertsuk, S., Charatcharoenwitthaya, P., Kaewdech, A., Chamroonkul, N., Chan, W. K., … Kim, W. R. (2023). THE UTILITY OF SEQUENTIAL SAFE SCORE AND FIBROSCAN IN PREDICTING CLINICALLY SIGNIFICANT FIBROSIS IN ASIAN NAFLD PATIENTS. HEPATOLOGY. LIPPINCOTT WILLIAMS & WILKINS.

Chronic Hepatitis B baseline viral load and on-treatment liver cancer risk: A multinational cohort study of HBeAg-Positive patients.
Choi, W.-M. M., Yip, T. C.-F., Kim, W. R., Yee, L. J., Brooks-Rooney, C., Curteis, T., … Lim, Y.-S. S. (2024). Chronic Hepatitis B baseline viral load and on-treatment liver cancer risk: A multinational cohort study of HBeAg-Positive patients. Hepatology (Baltimore, Md.).

OPTN/SRTR 2022 Annual Data Report: Liver.
Kwong, A. J., Kim, W. R., Lake, J. R., Schladt, D. P., Schnellinger, E. M., Gauntt, K., … Israni, A. K. (2024). OPTN/SRTR 2022 Annual Data Report: Liver. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 24(2S1), S176–S265.